Freedom of Information

FOI 5363 –

1.What was the total budget allocated for employee rewards and recognition programs in 2022, 2023, and 2024 (to date)? Please provide a breakdown by year.
2.How many employees would be eligible to receive Employee Rewards or Recognition?
3.How frequently are rewards payments made (i.e., weekly, fortnightly, 28 days, calendar month or annual)? Please provide a breakdown.
4.Besides employee rewards, for what other purposes does your NHS trust use gift cards or vouchers? For example, flu vaccination, stop smoking campaigns, etc.
5.Does your trust use prepaid cards for any purposes? Such as grants, medical trial rewards or targeted campaigns (Gluten Free).
6.How many gift cards, prepaid cards and vouchers has the Trust issued in 2022, 2023 & 2024? Please provide a breakdown of the solutions (prepaid, physical gift cards, digital gift cards and vouchers) used across the time frame provided.
7.Who is your current supplier(s) for above stated solutions (gift cards, prepaid cards and vouchers) and what is the current contract length with each supplier?
8.What is your anticipated 2025 budget for the above stated solutions (gift cards, prepaid cards and vouchers)?

FOI 5365 –
Information about the usage and supplier management of the RM6281 Workforce Alliance framework within the Trust. Please respond to the following questions:
1.Supplier Addition (Lot 1 under RM6281):7
o How many approved suppliers have been added to the Trust’s supplier list for Lot 1 under RM6281 from 1st July, 2024 to 30th October 2024?
2.Framework Usage Confirmation:
o Does the Trust currently use the RM6281 framework or Total Workforce Solutions HTE for staffing requirements?
3.Preferred Supplier List (PSL):
o What are the names of the agencies on your PSL that supply agency staff under Lot 1 RM6281 framework or Total Workforce Solution HTE, and what tier is each agency assigned to?
4.Shift Booking Above NHSE Capped Rate:
o How many shifts were booked above the NHS England capped rate from 1st July, 2024 to 30th October 2024?
5.Spending on Off-Framework Agencies:
o What was the total spend on off-framework agencies from 1st July, 2024 to 30th October 2024?
o What are the names of these agencies, and what reasons are there for their continued use despite NHS England’s restrictions?
6.Spend on Approved Framework Suppliers:
o What was the total spend on approved framework suppliers between 1st July, 2024 to 30th October 2024?
o In which area of specialty within Lot 1 does the Trust require a supplier that can book shifts within the capped rate to avoid breaches?
o If applicable, what are the reasons for breaches of the capped rates for shifts?
7.Framework Supplier Addition:
o Would the Trust add an approved framework supplier immediately if it could help reduce breaches of the NHSE capped rate?
8.Spending on Framework Agencies:
o How much was spent on framework agencies from 1st July, 2024 to 30th October 2024?
9.Supplier Selection Process:
o Does the Trust use Direct Award or Further Competition to select suppliers?
o What criteria are used to select suppliers, and is the Most Economically Advantageous Tender (MEAT) principle applied?
10. Audit Trail for Contract Awards:
o Could you provide a documented audit trail showing how contract awards were made, particularly for direct awards? This documentation should align with RM6281’s Framework Schedule 7, which requires clear justification and transparency in awarding contracts.
11.Neutral Vendor Information (if outsourced):
o If a neutral or master vendor is used, please provide the organisation’s name, contact person, email, and office contact number.
12. Further Competition and Framework Adherence:
o What was the date of the last further competition conducted?
o Has the Trust fully transitioned to using RM6281 and followed the guidance in Schedule 7 for supplier selection?
o Can you confirm adherence to the MEAT guidance provided in the framework?
13.Agency Spend Clarification:
o We have reviewed your organisation’s FOI website but could not locate the requested information. If any part of these questions is unclear or incomplete, please provide a full response or reach out for clarification.

FOI 5366 –
Response to the FOI 5181 submitted to you in June 2024:
1. How many GP appointments were taken where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weight loss drugs were given as a reason for the appointment in every year between 2018 and 2023. Please give a figure for each year.
2. How many A&E attendances were there where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason for the attending in every year between 2018 and 2023. Please give a figure for each year.
3. How many deaths were recorded where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weight loss drugs were given as a reason in every year between 2018 and 2023. Please give a figure for each year.

FOI 5370 – Request for a missing file for August 2024 Spend/Transparency data, available on the following weblink:

Finance and Performance

FOI 5373 – What is the current number of Retrospective Continuing Healthcare applications that are awaiting assessment and MDT panel.

FOI 5333 – 1.How have you spent the women’s health hub financial allocation from NHS England? Please provide a breakdown on how this money has been spent and on what services.
2.Please describe your approach to provision of a women’s health hub in your area.
3.How have you promoted this to women in your area?
4.What, if any, women’s health budget are you yet to spend from this allocation?
5.Have you determined how you will spend this yet and if so, please provide details.
6.Have you allocated any further funding to improve women’s health services in the coming year?
7.How did you detrmine how to spend the two year allocation?
8.What was the governance process for this decision?
9.How did you involve local women in this process?
10.What did local women tell you they needed to improve their health and wellbeing?
11.Once the two year allocation for women’s health is spent, how do you propose to continue to support women’s health and wellbeing?
12.Are there any reports on women’s health that you can share?
13.Do you have a one stop shop approach to women’s health? If yes, please can you provide details. If no, why not?
14.Would you be interested in finding out more about a clinically developed service which includes signposting to women’s health advice and charities, a forum for women to discuss women’s health issues, online and face-to-face information sessions with a GP, coaching services to support women.
15.Please provide the name and contact details (email and phone) for your lead commissioner for women’s health within your ICB, your women’s health champion, the director responsible for women’s health, and the person on your governing body with a special interest in/responsibility for women’s health.
16.Do you have a women’s health strategy or plan in place? Please share.
17.Do you plan to develop a women’s health strategy or plan and if yes, what is the timescale for this and how do you plan to involve women in its development?

FOI 5334 – Policy, process and procedure by which the relevant authority will consider the application by the Practice to close the Boxford site.

FOI 5335 – Dynamic Support Register (DSR).
1.Does your organisation deliver the DSR service?
2.If your organisation works with others to deliver, please name all the other organisations eg the names of local authority or mental health trust etc involved?
3.Do you have a digital DSR?
4.Do you have a digital dynamic risk register in place?
5.How many individuals do you have in total on your DSR?
6.Can you break them down into Red, Amber and Green and if so, how many of each do you have?
7.If so what sort of system is it, please state type eg spreadsheet, database or specialist software and if specialist software, state the name of the software supplier.
8. Regarding connectivity of the system in use, does this system integrate with other local systems such as NHS spine, RIO patient demographic service, Emis, SystmOne, Vision etc.
9. Is the system DTAC compliant?
10.If the system was purchased, what is the value of the contract for the system?
11. When was the system purchased?
12. If there is a contract for the current system when does the contract end, state any known break clauses and notice periods?
13. How many WTE staff do you have involved in supporting the DSR system?
14. Who are the leads responsible (person and role) for the managing and procurement of the system?

FOI 5336 –
1. The amount during each calendar year for each of the last five years your trust has lost to fraud and scams. This would include the year to date as one of those five years.
2. For each fraud or scam of more than £500 the nature of the fraud or scam, particularly:
1. The date the money was lost
2. How much was lost
3. How the money was lost – the precise methodology the scammers used
4. What efforts were made to reclaim the lost funds
5. How successful those efforts were.
6. Who the perpetrator was, if that is known.

FOI 5337 –
1. The details of any office accommodation your organisation provides to staff to carry out trade union business. Please include details of:
•space measured in square feet
•how much of this space is contained within entirely separate buildings (i.e. occupied solely by staff carrying out trade union business)
•whether a professional valuation of the market rental value of the space has been sought either in-house or externally, and if so, what the valuation of the space was
•any charges the council levy for office space given to trade unions.
2. Do you deduct trade union subscriptions for any of your employees via payroll (sometimes known as the “check off” system)? If so, do you charge a fee to the trade unions concerned for providing this service?
3. With regard to trade union facility time, please provide the total cost of facility time from your pay bill for the financial year 2023/24 and the budget for the current financial year. Please also advise the current number of employees that you fund to be union officials, measured as full time equivalents? (For guidance on definitions please refer to the Government’s Transparency Code for local government: https://www.gov.uk/government/publications/local-government-transparency-code-2015/local-government-transparency-code-2015)
4. Please advise any estimates for other costs met for those staff on trade union facility time apart from salaries – including travel expenses, office supplies, telephone expenses and energy bills.

FOI 5338 – Information regarding supported living services for adults (aged 18-64) with a primary support need of learning disabilities (LD). Please also include data for adults (aged 18-64) with Autism Spectrum Disorder (ASD) where information is captured for this cohort or where this is recorded as a primary support need

FOI 5339 – A list of the top 100 independent service providers (“ISP”) that the ICB has paid in relation to outsourcing NHS funded services in the following areas, ranked by amount of fees paid:
o Ophthalmology
o Gastroenterology (including Endoscopy/ Gastroscopy – if possible shown separately)
o Dermatology
o ENT services
• Within that list please include the following information:
o Name of the ISP
o Year first outsourced to this ISP
o Fee paid to this ISP in FY2023/2024
o Fee paid to this ISP in FY2022/2023
o Fee paid to this ISP in FY2021/2022
o Fee paid to this ISP in FY2020/2021
Please also share a general register or directory of companies that the ICB outsources to across all healthcare service verticals, including the applicable vertical for each company.

FOI 5340 – Information linked to all CHC funded packages for the ICB, for both children and adults?
• What is the monthly, quarterly and annual CHC spend for adults?
• What is the monthly, quarterly and annual CHC spend for CYP?
• What levels/volumes of referrals in total package hours that you put out to market each week/month/quarter/year, based on the last 12 months activity, for both children and adults?
• What are the numbers of package types referred by the ICB CHC team monthly, quarterly, annually, based on the last 12 months, covering the following conditions –
a. Spinal injury,
b. ABI,
c. Tracheostomy and ventilation,
d. Long term complex conditions.

FOI 5341 –
1. In your integrated care or health board:
a) do you commission pain services in the community:
If yes, please name location/s:
b) do you commission pain services in secondary care:
If yes, please name location/s:
c) do you commission pain services in tertiary care (highly specialised services:
If yes, please name location/s:
d) do you commission alternative providers to provide pain services:
If yes, please name alternative providers and location of services:
e) Do you commission social prescribers:
If yes, please state how many:
f) In the past three years have you decommissioned pain services in your region?
If yes, please list decommissioned services?
If yes, are you commissioning alternative services such as Lifestyle Management or similar instead?
If yes, please provide details.

FOI 5342 – Perinatal Pelvic Health Services within Trust
Please could you provide the name, Job title and email address of the person within the orgainzation that holds the following Job title or responsibilities.
1.ICB PPHS Clinical lead
2.The Transformation / “Project management” / Delivery person(s)
3.The commissioner or budget holder
4.PPHS Project Manger
5.Pelvic Health lead
6.ICB / Local Maternity and Neonatal System Prevention Lead
7.ICB / Local Maternity and Neonatal System Programme Lead
8.Transformation Project Midwife
9.ICB / LMNS Project Manager/Midwife
10.ICB Commissioning Manager
11.ICB LMNS Programme Lead & Maternity Commissioning Lead
12.Senior Programme Manager LMNS
13.Maternity & Neonatal Transformation Lead
14.Commissioning officer | LMNS Maternity Transformation
15.Assistant Director of Maternity Programmes
16.Programme Manager Perinatal Pelvic Health Services
17.Associate Director Maternity & Early Years
18.Implementation Manager Perinatal Pelvic Health Service.

FOI 5343 –
1. Which provider(s) are currently contracted to deliver MSK Physiotherapy services in your ICS region?
2. What is the duration and value of the current contract(s)?
3. When is the contract due for renewal or re-tendering?
4. Is it possible to obtain a copy of the current service specification for MSK Physiotherapy services?
5. Are there any plans for service redesign or changes to the contracting model for MSK services in the near future?
6. Who is the key contact person for MSK services commissioning within your ICS?

FOI 5345 –
1.Do you offer a specialist Memory Assesment Service? If no, how otherwise are people with memory problems diagnosed?
2.If you have a specialist MAS,
a.are people routinely offered a brain scan: either CT or MRI, and if so which?
b.which professionals are available as part of the memory clinic service offer, e.g., psychiatric nurse, general nurse, old-age psychiatrist, neurologist, psychologist, occupational therapist, social worker etc, please state
c.once people have received a diagnosis, what is the standard offer in terms of post diagnostic support? Please describe
d.does the memory clinic keep people on for regular review or are they discharged to their GP or another service?

FOI 5346 –
1. Does ICB have a children’s palliative care service specification? (Yes/No). If so, please attach a copy to your response to this request.
2. Has the ICB completed an Ambitions for Palliative and End of Life Care self-assessment? (Yes/No). If yes, please attach your completed self-assessment to your response to this FOI request.
3. Does ICB have a children’s palliative care service specification which states that infants, children and young people with a life-limiting condition and their parents or carers should have opportunities to be involved in developing an advance care plan? (Yes/No)
4. Does ICB have a children’s palliative care service specification which states that infants, children and young people with a life-limiting condition should have a named medical specialist who leads and coordinates their care? (Yes/No).
5. Does ICB have a children’s palliative care service specification which states that infants, children and young people with a life-limiting condition, their parents or carers and their siblings should be given information about emotional and psychological support, including how to access it? (Yes/No)
6. Does ICB have a children’s palliative care service specification which states that infants, children and young people with a life-limiting condition should be cared for by a multidisciplinary team that includes members of the specialist paediatric palliative care team? (Yes/No)
7. Does ICB have a children’s palliative care service specification which states that siblings and parents or carers of infants, children and young people approaching the end of life should be offered support for grief and loss when their child is nearing the end of their life and after their death? (Yes/No)
8. Does ICB have a children’s palliative care service specification which states that infants, children and young people approaching the end of life and being cared for at home should have 24-hour access to both children’s nursing care and advice from a consultant in paediatric palliative care? (Yes/No)
a. Note: We would like to capture those areas where registered nurses can provide both core and specialist children’s palliative care to children with a range of medical complexity. We acknowledge that, where this is provided, it is done so by nurses with different roles, employed by the NHS and/or the voluntary sector. This will include specialist children’s palliative care nurses providing care directly or providing advice to other nurses providing direct care.
b. Note: NHS England state that specialist children’s palliative care teams should be led by specialist medical consultants. These specialist consultants are vital because they:
i. Have specialist expertise in managing life-threatening illness and life-limiting conditions across the paediatric spectrum.
ii. The ability to manage the full range of symptoms experienced as disease and illness progresses.
iii. Lead and develop services within their region.
iv. Enable, support, teach and train other health care professionals.
9. Do you have a children’s palliative care service specification which states that infants, children and young people with a life-limiting condition and their families should have access regular short breaks for respite? (Yes/No).

FOI 5348 – List of all PCN’s that fall within the ICS / ICB to include
• Name of PCN
• Name of Clinical Director
• Email of Clinical Director
• Name of Digital Transformation Director
• Email of Digital Transformation Director
• Name of Practise Manager
• Email of Practise Manager

FOI 5349 – For each of the following calendar years (2018, 2019, 2020, 2021, 2022, 2023, 2024), please provide figures for the number of people who have delivered foetuses beyond 12 weeks as a result of using abortion telemedicine services.

FOI 5350 – What is the name of the ICS / ICB NHS Radiology Imaging Network and what is the contact details for it.

FOI 5352 –
1.What is the current utilisation percentage specifically for the virtual ward beds that are enabled for remote patient monitoring (rather the overall utilisation including used for face-to-face consultations)?
2.Does the utilisation of the remote patient monitoring-enabled virtual ward beds fluctuate over time? If so, could you provide an average percentage or a breakdown of utilisation across different time periods?
3.If you are unable to provide the utilisation percentage(s), could you explain the process used to capture and measure the utilisation of the remote patient monitoring-enabled virtual beds?

FOI 5353 – What is the local treatment guidelines, pathways or protocols for treatment of COVID-19 infection.

FOI 5354 – Provide any information relating to engagement with or consultation with the ICB by ESNEFT about the proposals for future of soft facilities management services change.

FOI 5355 – Current rates for Domiciliary/Homecare care supply; both framework and out of framework rates. This should be for care staffing supply across all ages; children, young people and adults and the point of contact regarding Homecare supply engagements (Tendering or spot purchase) . This could be supplier engagement officer, commissioning support team, etc. Please include:
Name of the officer in charge
Email
Phone Number

FOI 5356 –
1.Copy of NHS Suffolk And North East Essex Integrated Care Board’s system-level plan for patient choice
2.The name and (work) contact details for NHS Suffolk And North East Essex Integrated Care Board’s system-level patient choice Senior Responsible Officer.

FOI 5357 –
1.Do you currently provide earwax removal services at your practice/in your area according to NICE guidelines?
2.If not, do you provide a conditional/limited service or not at all? What is the reasoning behind not providing the service to NICE guidelines?
3.If you offer earwax removal, what are typical waiting times, weekly availability and demand?
4.If you do provide earwax removal, what percentage of patients requiring earwax removal are provided the service?
5.What percentage of patients requiring earwax removal are hearing aid users?
6.What percentage of earwax removal appointments are provided using:
• Microsuction
• Irrigation
• Other techniques
7.What percentage of patients requiring earwax removal are not suitable for irrigation due to the contradictions laid out in the earwax removal care pathway (attached)?
8.What percentage of patients that have undergone irrigation are referred for microsuction due to irrigation being unsuccessful as described in the earwax removal care pathway (attached)?
9.If you refuse some/all patients the service, what percentage do not have their earwax removed elsewhere and return with similar symptoms? Out of these returning patients, how many require referral to a specialist due to worse symptoms/complications?
10.We are currently in the early stages of developing an earwax removal device, and we would like to validate our value proposition to the NHS.

FOI 5293 –
1. What Long COVID clinics are currently open within the Trust?
2. Have any Long COVID clinics within your Trust closed in the current year?
3. Are any of your existing Long COVID Clinics intending to close in the near future?

FOI 5294 –
1. What was the ICB’s total spend on Children’s Mental Health between April 6 – April 5 2023/24? What percentage of the overall ICB budget was spent on it?
2. What is the total number of children (Under18) referred to CYPMHS/ CAMHS between April 6 – April 5 2023/24?
3. What is the percentage of the U18 population and/or the figure of the U18 population within the ICB.
4. What is the total number of children on the waiting list for mental health treatment within the ICB?
5. What is the average waiting time for children’s mental health treatment with the ICB?

FOI 5295 – List of all the NHS-registered dental practices in the ICB.

FOI 5296 – Does the LES/DES service include postoperative wound management?
Does the LES/DES service include traumatic wounds e.g. trauma and skin tears?
Does the LES/DES service include complex wound care?
Does the LES/DES service include pressure ulcer prevention or pressure ulcer wound care? Y/N If yes:
what prevention activities are included?

Y/N If yes:

what is the inclusion criteria?
what is the exclusion criteria?
what is the claim amount?
what pressure ulcer treatment is included?

FOI 5297 – The procurement and award of contracts under Lot 1 of the Workforce Alliance RM6281 framework for providing temporary nurses and clinical staffing. I kindly request your assistance in addressing the following inquiries:
1.Compliance with Public Contracts Regulations 2015: Please provide information on how the Trust ensures that the awarding of contracts under Lot 1 of the Workforce Alliance RM6281 framework adheres to the Public Contracts Regulations 2015.
2.Non-discrimination and Fairness: How does the Trust ensure that it does not discriminate or act unfairly towards suppliers when selecting contractors under this framework?
3.Supplier Invitation: Does the Trust invite all approved suppliers under the framework to bid or supply services, as stipulated by the framework’s rules? If so, could you provide evidence or examples of this process in practice?
4.Supplier Selection Process: Please outline the legal justification the Trust uses when selecting certain suppliers while excluding others under the Workforce Alliance RM6281 framework.
5.Compliance with Selection Criteria: Could you explain the process by which suppliers are selected under the framework, particularly concerning ensuring compliance with the selection criteria set out in the Workforce Alliance RM6281 framework and the Public Contracts Regulations 2015?
6.Further Competition Process: Could you describe the process your Trust follows for further competition under the Workforce Alliance RM6281 framework? Specifically, do you use direct awards, or do you invite suppliers for further competition for Lot 1? Please provide evidence to support your response.
7.Evidence of Compliance: Kindly provide any documentation or evidence demonstrating how the Trust ensures compliance with the aforementioned regulations and framework rules when awarding contracts under Lot 1 for the provision of temporary nurses and clinical staffing.
8.Legal Queries and Proceedings: Please provide contact details (department and individual, if available) for submitting legal queries or initiating legal proceedings related to procurement processes under this framework.

FOI 5298 – Does your organisation commission cognitive interventions, including Cognitive Stimulation Therapy (CST), as part of post-diagnostic services for dementia patients?
What is the current allocated budget for cognitive interventions, specifically CST, for the 2024/2025 financial year?
Please provide the budget allocations for CST for the financial years 2021/2022, 2022/2023 and 2023/34.
Please provide the overall budget allocation for memory services
What is the average waiting period for patients to access commissioned cognitive interventions, including CST?
Who are the main providers of your cognitive interventions to dementia patients?
What recorded plans or strategies does your organisation have to expand access to CST?
How many CST groups are currently commissioned to run concurrently across your area?
Does your organisation commission online CST services? If so, how many online CST groups are funded per year?
What is the current funding model for CST provision in your area?

FOI 5299 – Does the Integrated Care Board have established referral pathways for patients to access employment support programmes?
Please provide a list of all current employment support programmes that the Integrated Care Board is involved with (A) commissioning or delivering (B) referring patients to.
How many patients have been referred to employment support programmes for each of the last five years?
Has the ICB entered into any agreements or partnerships with the Department for Work and Pensions concerning patients who are out of work? If so, please provide copies or details.
Has the ICB prepared a written strategy or policy document that sets out how you work with partners, including the Department for Work and Pensions, to support patients out of work due to ill-health or disability to return to work? If so, please provide this.

FOI 5300 – As an Integrated Care System:
1.Do you have a dedicated Dementia Strategy Lead in post?
2.Do you have a current Dementia Strategy?
a)If yes, please could you provide a copy or a link to a copy of your current dementia strategy.
3.Do you have a dementia specific steering group?
a)If so, please could you provide a contact email address.

FOI 5301 – For the financial year of 2022/2023 what did the ICB/ICS spend (please provide a value) on bringing patients registered in their ICB/ICS who have fallen ill within the borders of another ICB/ICS and needed to be repatriated.

FOI 5302 – Alopecia questions:
Section 1: Patient pathways and prescription
1.Do you have a patient pathway for alopecia?
1.(a) If yes, what does it say, and when was it last reviewed, does it include referral from primary to secondary care?
1.(b) If no, please explain any reasons for what has prevented this (e.g. budgets, other priorities, other organisations’ responsibility).
1.(c) If no, do you prescribe some off license treatments (e.g. topical steroids) in your area (area is defined as all the local Trusts that are relevant to your ICB, serve your ICB area, or are commissioned by your ICB, for which you are responsible to fund or commission treatment?
2. Are patients with alopecia areata in your ICB area able to be prescribed ritlecitinib, as approved by NICE technology appraisal guidance TA958 (area is defined as all the local Trusts that are relevant to your ICB, serve your ICB area, or are commissioned by your ICB, for which you are responsible to fund or commission treatment)?
2.(a) If yes, could you provide information on any policy or limitations on the number of patients with alopecia areata that can be prescribed ritlecitinib?
2.(b) If no, or if any limitations are present, please explain any reasons for not adhering to NICE’s mandatory guidance (e.g. budgets, other priorities, other organisations’ responsibility).
Section 2: Clinics and referrals in your area
3. Are you currently referring alopecia patients to secondary/tertiary care?
3.(a) If yes, please explain the referral criteria, including whether referrals are for virtual or in person appointments?
3.(b) If no, what is preventing this? (e.g. budgets / other priorities / other organisations’ responsibility)
4. What is the average time for a patient with alopecia to be referred to secondary/tertiary care within your ICB area?
Section 3: Wigs
5. Do you have a wig policy for patients with alopecia in your ICB area (area is defined as all the local Trusts that are relevant to your ICB, serve your ICB area, or are commissioned by your ICB, for which you are responsible to fund or commission treatment)?
5.(a) If so, what does your policy state regarding the provision of wigs for alopecia patients? Specifically, please address the following:
• Are all types of alopecia eligible for a wig?
• How many wigs are provided to patients per year?
• Are there any limitations on the type of wig available (e.g. acrylic or human hair wigs)?
• Do patients have a choice of supplier? And if so, how many?
• How do patients pay for their wigs?
• Are patients allowed to pay a top-up to the prescription to get a wig that costs more?
5.(b) If no, what has prevented this so far?
Section 4: Mental Health
6. Are the associated mental health or psychological challenges of patients with alopecia assessed in your ICB area (area is defined as all the local Trusts that are relevant to your ICB, serve your ICB area, or are commissioned by your ICB, for which you are responsible to fund or commission treatment)?
6.(a) If yes, please explain what specific support is available, whether people are signposted to relevant support organisations, and if there is any criteria to receive support (e.g. percentage of hair loss, type of alopecia)?
6.(b) If no, please explain what has prevented this so far?
Section 5: Awareness of local population
7. Have you reviewed the alopecia needs of your local population (e.g. numbers of people living with alopecia who are diagnosed and not yet diagnosed, gender, ethnicity, socio-economic groups)?
7.(a) If yes, please give details.
7.(b) If no, what has prevented this and are there plans to do so?
8. Are you aware of local inequalities of access to care services for people with alopecia amongst any groups (e.g. by gender, ethnicity, socio-economic groups)?
8.(a) If yes, please give details of the inequalities and any work you are doing or planning to do to address this.
8.(b) If no, are there plans to do so?

FOI 5303 – How many members of the Board of the East Suffolk and North Essex NHS Foundation Hospital Trust (a) are current employees of the National Health Service; (b) are former employees of the National Health Service; and (c) have never been employees of the National Health Service.What is the first half of the Post Code of each member of the Board of the East Suffolk and Norh Essex NHS Foundation Hospital Trust.

FOI 5304 – What are the product names with start and finish dates of all your agreed primary care rebates as of September 2024.
What is the process of how you review and evaluate the rebates presented to ICB?
A copy of up to date primary care rebate policy.

FOI 5305 –
1. What is the sum spent by the ICB/paid by the ICB to organisations in the voluntary, community and social enterprise sector (VCSE), including charities, in a) 2022-23 (either April 2022-March 2023; or July 2022 (when ICBs were created)-March 2023 –- whichever is held by your organisation – please specify; and in b) 2023-24;
2. What is the sum the ICB plans to spent on organisations in the voluntary, community and social enterprise sector (VCSE), including charities, in 2024-25;
3. What is the sum paid in grants by the ICB/paid by the ICB to organisations in the voluntary, community and social enterprise sector (VCSE), including charities, in a) 2022-23 (either April 2022-March 2023; or July 2022 (when ICBs were created)-March 2023 –- whichever is held by your organisation– please specify; and in b) 2023-24;
4. What is the sum the ICB plans to pay in grants to organisations in the voluntary, community and social enterprise sector (VCSE), including charities, in 2024-25.

FOI 5306 – Who is currently responsible for the neurodevelopmental (ND) right to choose process?
Who is responsible for signing off the invoices in relation to work performed by an accredited right to choose provider?

FOI 5307 – Total number of women who used maternity services at the ICB for the years 2021-2023 (to include antenatal care, labour and birth, and post-natal care.)

FOI 5308 – What are the budgets allocated and spend to date (current and last 2 financial years) for the insulin pump technologies (insulin pump provision and hybrid closed loop provision) for each of the diabetes pump teams under your overall funding responsibility.
Please break these down by:
•paediatric
•adult
for each pump team in West Suffolk, East Suffolk and North East Essex.
In addition please state this against the type 1 population (paediatric and adult) each team serves.

FOI 5309- What is the ICB’s Elective Recovery Funding (ERF) % Target for 24/25
What is the year to date performance against the ICB ERF % Target for 24/25 – Please advise which month the year to date performance relates to.
Provide for each Trust within the ICB their individual ERF % Target for 24/25.
Provide for each Trust within the ICB their performance year to date against their individual ERF % Target for 24/25 – Please advise which month the year to date performance relates to.

FOI 5310 – For each year from 2021-2023 inclusive, please provide the total budget for maternity services per integrated care system, broken down by antenatal care, labour and birth, and post-natal care [as classified by the NHS as 6-8 weeks]. Please break the figures out by year and by sub-type [ie. antenatal care, labour and birth, and post-natal care].

FOI 5311 – How many NHS Dental Care Complaints has the ICB received in the last 5 years [Between
April 6 – April 5 2019/20, 2020/21, 2021/22, 2022/23, 2023/24] Broken down by year.
For the last year alone (2023/24), can you provide the 20 most common dental care complaints, including the number of complaints received.

FOI 5312 – Procurement and award of contracts under Lot 1 of the Workforce Alliance RM6281 framework for temporary clinical and healthcare staffing. I would appreciate your assistance in providing the following information:
1. Direct Award Method:
o Has your Trust employed the direct award method for sourcing workers or small groups of workers under the RM6281 framework? If so, please provide evidence demonstrating that the selected suppliers offered the most economically advantageous terms in accordance with the framework’s guidelines.
o What measures does your Trust implement to ensure transparency and fairness in direct award decisions, including maintaining a clear audit trail?
2. Further Competition:
o Has your Trust used the further competition process for awarding contracts where adjustments to the framework terms were necessary or where commercial benefits could be achieved? Please provide documentation detailing:
 The identification of the relevant lot.
 Invitations sent to all capable suppliers.
 Evaluation criteria used to determine the most economically advantageous tender.
 Evidence of a fair and transparent evaluation process.
3. Neutral or Master Vendor:
o If your Trust utilizes a neutral or master vendor to manage temporary staffing, how do you ensure these vendors comply with the framework’s requirements, including the Public Contracts Regulations 2015? Please provide evidence of compliance with the framework’s rules for transparency, fairness, and economic advantage.
o What processes are in place to monitor and audit the actions of neutral or master vendors?
4. Supplier Selection and Exclusion:
o Please explain how your Trust lawfully selects certain suppliers while excluding others under the RM6281 framework. What justifications are used for these decisions, and how do you ensure compliance with the framework and procurement regulations?
5. Processes for Supplier Selection:
o Could you outline the process your Trust follows when selecting suppliers for temporary clinical and healthcare staff under RM6281? This should include the decision-making steps for choosing between direct award, further competition, or engaging a neutral/master vendor.
o Please provide contact details for the department responsible for handling legal queries related to procurement under the framework.
6. Additional Information:
o The total number of agencies listed under Lot 1 and the rates at which they supply their services.
o The name of the master or neutral vendor managing shift allocation.
o If your Trust is not using the Workforce Alliance RM6281 framework, please specify which framework is currently in use.

FOI 5313 – How many GPs are currently directly employed by your ICB?
What proportion of those GPs are employed on the BMA salaried GP model contract or terms equivalent to the BMA salaried GP model contract?
For any GPs employed by the ICB on terms not equivalent to the BMA salaried GP model contract, how do their contracts differ from the BMA salaried GP model contract?

FOI 5314 – List of all hospitals registered with the Care Quality Commission (CQC) within SNEE ICB area.
For each hospital, please provide:
1. The total number of beds.
2. A breakdown of total number of beds by bed types, as coded by the national definitions.

FOI 5315 – The level of early UDA repayments agreed between SNEE ICB and the holders of dental services contracts, as well as information on contract rebasing.
Information for the financial years ending March 2019, March 2020, March 2023, March 2024. If the number of periods requested is a barrier to providing the information, please provide data for years ending March 2023 and March 2024 (i.e. the last 2 years).

FOI 5316 – ICB / NHSE annual spend on:
– Emis
– Systm1
– AccuRx
– Patchs
– eConsult
– Anima
– Ardens
– PCIT
What other software providers are used in primary care which are purchased at ICB level.

FOI 5317 – Copy of FOI request 5304.

FOI 5318 – PCN Test Sites Programme
1.Has ICB chosen the PCN pilot sites?
2.Name the PCN sites.
3.Point of contact at the PCN and their job role?
4.When will/has the pilot begun in each of these sites?
5.Who is the person responsible for the pilots at the ICB? What is their name and job role?
6.Does this ICB staff member spend time in the PCN practices as part of the pilots, and if so, how often and for how long will they do this?
7.How is the programme organised? What is the process for carrying out the pilots?
8.As part of the pilot, there was meant to be a baseline established – of demand, resource, cost and economics. This was meant to be a three-week long process. Please confirm if each of the test sites has completed this yet, and if not please name which sites have not yet undergone this.
9.Following this baseline, interventions (e.g. digital tools) were then intended to be established. These were meant to be done in-programme. Can you confirm which PCN sites have their interventions confirmed please?
10.And of those that have these interventions confirmed, please detail which interventions will be put in place for each PCN.
11.Following the decision on interventions, there will be an audit every 8 weeks for PCNs. Can you confirm the timescale for this please? When did/will the first of these audits take place?
12.If an audit has already taken place, can you confirm at which PCN? And what the results were of this audit?
13.How much is the pilot costing overall for the ICB?
14.Who is funding the pilot?
15.How much will each of the PCNs taking part in the pilot receive in funding? Please break this down per PCN involved.
16.When will this money/funding be released to them? If it has already been released, please provide the date on which this was released.

FOI 5319 – For the following clinics/services:
i) ME/CFS services (i.e., chronic fatigue syndrome or fatigue management services)
ii) Long COVID services (i.e., post-covid clinics)
iii) POTS clinics (postural orthostatic tachycardia syndrome / syncope – usually located within cardiology or a specialist autonomics unit).
Provide details for each clinic/service within your ICB:
i) Name of the service/clinic
ii) Address/location
iii) Telephone contact (for patient enquiries)
iv) Email address (for patient enquiries)
v) Public web-page
vi) Name/position of the lead clinician of the service

FOI 5320 – NHS England Increasing Capacity Framework (ICF)
1.Does the ICB keep a record of Provider organisations with which it holds contracts, and the means by which such contracts were awarded?
2.Please provide a list of providers who are listed on the ICF and with which the ICB has a contract in place for 2024/25 (or part year thereof) which was awarded through the ICF. For clarity, we are not interested in contracts held with ICF providers which were not awarded under the ICF.
3.For each provider contract awarded under question 2 above, please provide:
a. the method used to award the contract: Mini-competition or Direct
b. the expiry date of the contract
c. Schedule 2A

FOI 5321 – It is lawful for providers of NHS services to refuse to provide treatment where a patient’s behaviour constitutes as discrimination or harassment, or abusive violent or threatening, towards staff. Please can you tell me the number incidences where your Trust has refused treatment in the last five years?
Please present the data annually by financial year.

FOI 5322 – ICB’s full policy on providing adult containment products for patients suffering with incontinence.
Has ICB got a prescription limit (I.e three absorption pads per day) and if so, details of that limit is.
The total cost spent by the ICB on containment products for 2023/2024 (April 1 – March 31)
How many complaints you have had regarding adult containment products/prescriptions since January 1 2023.
For each complaint, please disclose a detailed summary of that complaint.

FOI 5323 – MSK, Orthopaedic, and Intermediate Care pathways within SNEE ICB
Service specifications for the overall pathway and its constituent parts.
Any relevant documentation or resources that would help us better understand how your MSK pathway operates.

FOI 5324 – Management of sedated patients in ICB’s hospital intensive care (ICU) unit(s).

FOI 5325 – 1.Total Spend and Volumes: The total spend (in £) and volume (number of procedures) for both in-house and outsourced provisions for each of the following ophthalmology procedure groups:
oCataract surgeries
oAMD – eye injections
oAMD – photodynamic therapy
LASIK
SMILE
oCorrective laser eye surgeries (e.g. PRK, LASEK, TransPRK)
If your records use different categorisations or sub-categories within these procedure groups, please provide the total spend and volumes for those as well.
2.Outsourcing Spend and Volumes by provider: The volume and spend for each ophthalmology procedure group outsourced, broken down by specific private providers. Please specify the volume and spend for each of the following procedure groups for each provider:
oCataract surgeries
oAMD – eye injections
oAMD – photodynamic therapy
LASIK
SMILE
oCorrective laser eye surgeries (e.g. PRK, LASEK, TransPRK).

FOI 5327 –
Steps taken to adopt digital solutions and technologies with the goal of transforming services and reducing carbon footprint.
1. Companies contracted to provide the following:
a. Photocopiers/MFDs
b. Printers
c. Print room / reprographics
d. Desktop Scanners
2. Manufacturers of equipment used for the following (if different to Q1)
a. Photocopiers/MFDs
b. Printers
c. Print room / reprographics
d. Desktop Scanners
3. Length of contract/s and end dates? (Please advise of any extensions available)
a. Photocopiers/MFDs
b. Printers
c. Print room / reprographics
4. Number of devices?
a. Photocopiers/MFDs
b. Printers
c. Print room / reprographics
d. Desktop Scanners
5. Details on how these were procured. i.e. By Framework
a. Procurement method
b. If Framework, please state which framework was utilised
6. Do you have any print management software e.g. PaperCut, Equitrac? If so, which
software?
7. Does the Authority have a Hybrid or Digital Mail Service, if so, who supplies this and when does the contract expire?
8. Do you utilise any Document and / or Content Management systems, if so, which?

FOI 5328 – Question regarding NHS Continuing Healthcare in the NHS Suffolk and North East Essex ICB area in respect of people living with Progressive supranuclear palsy (PSP) and Corticobasal degeneration (CBD, sometimes referred to as corticobasal syndrome or CBS).
1.Please confirm the number of people in the NHS Suffolk and North East Essex ICB area with PSP and CBD who were receiving NHS Continuing Healthcare in the years 2021, 2022, 2023 and 2024.
i.People with PSP
ii.People with CBD
2.Please confirm the number of applications for NHS Continuing Healthcare that the NHS Suffolk and North East Essex ICB received in the years 2021, 2022, 2023 and 2024 in respect of:
i.People with PSP
ii.People with CBD
3.Of the above applications for NHS Continuing Healthcare in respect of people with PSP and CBD, please confirm the number which were:
i.Approved (found eligible for Continuing Healthcare)
ii.Rejected (found ineligible for Continuing Healthcare)
4.Of the above applications for NHS Continuing Healthcare in respect of people with PSP and CBD that were approved, please confirm the number which were for Fast Track Continuing Healthcare.
i.People with PSP
ii.People with CBD
5.In respect of applications for Continuing Healthcare in respect of people with PSP and CBD that were rejected, please confirm the number of applications that rejected due to:
i.Failed initial assessment (NHS Continuing care checklist)
ii.Failed full assessment (CHC Decision Support Tool)
iii.Other (please specify).

FOI 5329 – Information about all installed Xray Systems in the hospitals.

FOI 5330 – Data on last 3 years of discretionary spend for primary care for IES, East Suffolk and NEE, also a proportion of ICB overall budget.

FOI 5331 – PLACE based partnerships within ICB.
Which GP practices are within each of these place-based partnerships.

FOI 5332 – In June 2023 Hospice UK sent a Freedom of Information (FoI) request to you with 10 questions regarding PEoLC strategy, governance, shared care records, and hospice funding. Please could I have a copy of your response?

FOI 5260 – Cyber
1. How many cyber incidents (threat and breach) occurred in the last two years (1st of July 2022-1st of July 2024)?
2. For each of the following cyber incident types, please indicate if your organisation experienced them in any month from the 1st of July 2022- 1st of July 2024. If yes, specify the month(s) in which they occurred:
•Phishing attacks: Yes/No. If yes, which month(s)?
•Ransomware attacks: Yes/No. If yes, which month(s)?
•Distributed Denial of Service (DDoS) attacks: Yes/No. If yes, which month(s)?
•Data breaches: Yes/No. If yes, which month(s)?
•Malware attacks: Yes/No. If yes, which month(s)?
•Insider attacks: Yes/No. If yes, which month(s)?
•Cloud security incidents: Yes/No. If yes, which month(s)?
•Social engineering attacks (excluding phishing): Yes/No. If yes, which month(s)?
•Zero-day exploits: Yes/No. If yes, which month(s)
3. For each of the following supplier types, please indicate if any cyber incidents related to them occurred between the 1st of July 2022-1st of July 2024. If yes, specify the volume of cyber incidents that occurred:
•IT service providers: Yes/No
•Medical equipment suppliers: Yes/No
•Software vendors: Yes/No
•Cloud service providers: Yes/No
•Data storage/management companies: Yes/No
•Telecommunications providers: Yes/No
•Security service providers: Yes/No
•Managed service providers (MSPs): Yes/No
•Third-party payment processors: Yes/No
4. During the period from 1st of July 2022 -1st of July 2024, did your organisation experience any of the following impacts due to cyber incidents?
•Were any appointments rescheduled due to cyber incidents? Yes/No
•Was there any system downtime lasting more than 1 hour? Yes/No
•Did any data breaches occur? Yes/No
•Were any patients affected by data breaches? Yes/No
5. What percentage of your cybersecurity budget is allocated to each of the following supply chain security technologies? Please indicate the percentage for each:
•Third-party risk assessment tools: ___%
•Vendor management systems: ___%
•Supply chain visibility and monitoring solutions: ___%
•Secure data sharing platforms: ___%
•Multi-factor authentication for supplier access: ___%
•Endpoint detection and response (EDR) for supplier systems: ___%
•API security solutions: ___%

FOI 5261 – Ear wax removal
1.Does the integrated care board currently commission an ear wax removal service or services within primary care or community ear care services, available to all patients registered with GP practices within the ICS’s boundary, as per NICE guidance?
2.If a wax removal service in primary or community care is not currently available to all patients, is there a plan to set up such a service in future, or to review the need for this service? If no, why not?
3.If a wax removal service is commissioned, how can a patient access this service or services when it is considered clinically necessary and/or self-care advice, if appropriate, has been unsuccessful?
4.If the integrated care board does commission a wax removal service within primary care or community care, please provide the name or names of commissioned providers and their address or addresses.
5.Does the integrated care board have a policy or guidance on ear wax removal and/or referral pathways for its primary care providers for patients for whom the benefit of ear wax removal is clinically indicated? If the integrated care board has issued such guidance, please provide a copy.
6.Can you provide a copy of any guidance the integrated care board provides to patients and/or clinicians on the self-management of symptomatic ear wax?
7.How many complaints has the integrated care board received from patients about difficulty in accessing or inability to access a wax removal service in the last 24 months?

FOI 5262 – Lupus questions
How many children with lupus or suspected lupus have been referred rheumatology units by Colchester, by Ipswich?
Which rheumatology units are these?
How many children with suspected lupus or other connective tissue disorder are currently been seen by Colchester paediatrics ? By Ipswich hospital?
How many children between the ages of 12 – 16 did Colchester hospital diagnose with lupus? Ditto Ipswich hospital? How many children below the ages of 12 did Colchester diagnose with lupus ? Ditto Ipswich hospital?
What criteria does Colchester hospital use to formally diagnose lupus in children ? Ditto Ipswich? And if they cannot formally diagnose which hub hospital do they refer to?

FOI 5263 – Information regarding the use of the following clinical software systems at East Suffolk and North East Essex NHS Foundation Trust.

FOI 5265
1.How much money have GP practices within the ICS spent on EHR (Electronic Health Record software) over the last 12 months? If this information is available per practice (e.g. in a spreadsheet) please that would be great, if not a total sum of all GP practices in the ICS is fine.
2.More broadly, how much money have GP practices within the ICS spent on any type of software in the last 12 months? As per question 1, if this information is available per GP practice please that would be great, and if not a total sum of all GP practices in the ICS is fine.
3.How many full time employees (FTE) does the ICB directly employ who have a Digital, Data or Technology (DDaT) role?

FOI 5266 – Primary care rebates that are currently active in Suffolk & North Essex ICB.

FOI 5267 – Questions regarding Essential Business Software.

FOI 5268 – Details for key personnel within ICB:
1. Secondary Care Lead
2. Diabetes Lead
3. Sustainability Lead
4. Head of Infection, Prevention and Control
5. Microbiologist(s) sitting on the Infection, Prevention and Control Committee
6. Smoking Cessation Lead
7. Midwifery Smoking Cessation Lead

FOI 5269 – Questions regarding Storage & Cloud Infrastructure.

FOI 5270 – What is the policy for CAMHS system support meetings?
How many system support meetings were held in Essex between 01 Jan 2023 – 31 Dec 2023 and between 01 Jan 2024 – 9 Aug 2024 and how many children under the age of 16 have been subject to these meetings between the same dates above.

FOI 5271 – The provision of Non-Emergency Patient Transport Service (NEPTS), Pathology Specimen Courier, Special Educational Needs & Disability (SEND) Transport and Mental Health Transport at ICB.

FOI 5272 –
1.What is the amount allocated to the ICB under the Elective Recovery Fund (ERF) for each of the years 2021-22, 2022-23,. 2023-24
2.For each of the financial years 2021-22, 2022-23, 2023-24 provide a breakdown of expenditure and activity of the ERF according to the different categories of elective care and according to the provider organisation.

FOI 5273 – For the finical year of 2022/2023 what did the ICB/ICS spend on repatriating patients (moving patients who have fallen ill in your ICB/ICS back to their “home” ICB/ICS) from their region/ICB/ISC to another ICS/ICB in the country.

FOI 5274 – Does ICS have a Local Enhanced Service (LES) currently in place for Inclisiran (brand name: Leqvio).
•If YES, what is the start and end dates of the LES, and the terms of the contract
•if No, Has a LES for Inclisiran ever been in place within ICS?

FOI 5275 – Breakdown of ICBs spending on management consultants since the ICB was formed.

FOI 5276
1. Please can you provide details of
a. whether (as at August 2024) any of the following are used in your ICB area to support children’s care: telehealth and telemedicine technologies, MHealth apps, health information technologies, remote monitoring technologies, digital healthcare devices, wearable devices and telemedicine devices and/or any other technologies designed to facilitate personalised medicine not detailed above
b. The names/details of technologies being used
c. The purposes for which such technologies are being used. NB we are not asking for detailed information about the operation or implementation of these technologies, but merely the broad purposes for which they are being used.
2. In your ICB area, please can you advise what information clinicians are given about how data collected by such technology is processed, for what purposes, and with whom it is shared. Again, we are asking for information in broad terms e.g. whether information is shared with commercial entities/third parties and the status of those entities ie technology provider but not the names of those entities.
3. Please can you confirm what information doctors and other health professionals in your ICB area give/are advised to give to child patients and/or their parents about the benefits and risks of using such technology generally/specifically.
4. Please can you confirm what information doctors and other health professionals in your ICB area give/are advised to give to child patients and/or their parents about how data collected by such technology is processed, for what purposes, and with whom it is shared.
5. Please can you provide copies of all policies and documents that have been developed by or within the ICB with a view to ensuring that when NHS staff are advocating the use of such technology, children and parents’ information is processed in accordance with the UKGDPR.

FOI 5277 –
Is ICB commissioning or providing referral, diagnosis or treatment services for the following?
a. ASD in children
b. ASD in adults
c. ADHD in children
d. ADHD in adults
An overview of the current digital and physical care pathways, from referral for assessment to diagnosis and long-term treatment, for the above.
For the following financial years 2021/22, 2022/23 and 2023/24, provide split by ASD in Children, ASD in adults, ADHD in children and ADHD in adults.
a. Number of:
i. People referred for diagnosis assessment
ii. People screened/triaged and subsequently not assessed
iii. Diagnosis assessments completed
iv. People subsequently diagnosed with the relevant condition
b. Average (mean) waiting time from referral to assessment (in weeks)
4. What was the total expenditure by your organisation on mental health services, for each of the following financial years 2021/22, 2022/23 and 2023/24?
For the financial years 2021/22, 2022/23 and 2023/24, what is the expenditures by ICB, for ASD in Children, ASD in adults, ADHD in children and ADHD in adults.
a. Total expenditure
b. Split of expenditure by:
i. Screening/triage of referrals
ii. Diagnosis assessments
iii. Post-diagnosis treatment (including medication)
iv. Post-diagnosis follow-up
v. Other expenditures (please specify)
For all providers used since 2021/22 for the provision of ASD in Children, ASD in adults, ADHD in children or ADHD in adults services, please provide the following information:
a. Name of provider
b. NHS or independent provider
c. Categories of patients served (children ASD, adult ASD, children ADHD, adult ADHD)
d. Services provided for your organisation (e.g. screening/triage, diagnostic assessment, treatment, long-term follow-up)
e. Total expenditure by your organisation on their services for each of the following financial years 2021/22, 2022/23 and 2023/24
f. Number of people accessing their services commissioned by your organisation for each of the following financial years 2021/22, 2022/23 and 2023/24.

FOI 5278 – Questions about Double and Triple Lock Process.

FOI 5279 – Community Respiratory Service Mapping
Does the ICB commission community-based bronchiectasis services?
Does the ICB commission services dedicated to complex bronchiectasis e.g. those with frequent exacerbations, or comorbidities?
Does the ICB commission community-based services treat complex respiratory conditions such as COPD, interstitial lung disease?
If yes, please tell us:
Name of provider
Number of patients contracted/treated in the past year
Address of provider
High-cost drug propensity
Are the community service providers authorised to treat patients with any of the following drug types?
• Monoclonal antibodies
• Nebulised or infusion polymyxins / aminoglycosides antibiotics e.g. Colomycin or Gentamicin
• Other high-cost drugs
Resource utilisation
What is the total resource funding utilisation in social care for exacerbating bronchiectasis, in the last financial year?
What/how much is funded from NHS budgets?
What/how much is funded by social care budgets?

FOI 5280 – Name, job title, and contact details of the current Care, Education, and Treatment Review (CETR) lead within the NHS Suffolk and North East Essex ICB.

FOI 5281 –
1. Who currently provides the Trust with Hybrid Mail Services for the
• Main outpatients’ appointment system (PAS)
• Breast Screening Services
• Diabetic Eye Screening
2.Can you please provide the contact names & email addresses for the Managers responsible for Hybrid Mail at these locations.
3. What is the annual spend/annual volumes for these contracts.
4. When are these contracts up for renewal or is there a Hybrid Mail tender imminent.
5. Who looks after Hybrid Mail contracts within Procurement.

FOI 5282 – How many cyber incidents occurred in the last two years (1st of July 2022-1st of July 2024)?

FOI 5283 – Which NHS organisations or Local Authorities within your region are currently providing Child Obesity Clinics?

FOI 5284 –
1. Contact Information for PSL Management to supply your NHS Trust Nursing Staff:
• If the Trust utilizes NHS Professionals (NHSP) or an equivalent master vendor/neutral vendor, please include the contact details (name, job title, email address, and phone number) of the individual(s) responsible for onboarding third-party suppliers to the Trust via these vendors.
2. Process for Applying to the PSL for temporary nursing:
• Information on the process, criteria, and requirements for clinical agency suppliers to be considered and added to the NHS Trust’s Preferred Suppliers List.
3. Which Clinical Agency Staffing Framework is being used by the Trust for nursing? E.g RM6281/HTE.

FOI 5285 – What is the number of referrals received so far for spirometry since new form devised on DXS and what is the number of referral forms rejected at first attempt.

FOI 5286 – Digital Dictation
● Do you use Digital Dictation? If yes, could you please answer the following questions:
○ Name of the supplier & product?
○ How many user licences do you have?
○ What procurement method (if any) was used to obtain this system, i.e. what framework?
○ The contract start date?
○ The contract expiry date?
○ Total contract value?
○ Is the product integrated with PAS or EPR?
○ What is the name(s) and position(s) of the key internal stakeholder(s) for this service?
○ What is the person(s) email and telephone number?
○ What would you like to see in this product that is currently not being delivered?
Outsourced Transcription
● Do you use Outsourced Transcription? If yes, could you please answer the following questions:
○ Name of the supplier:
○ What procurement method (if any) was used to obtain this system, i.e. what framework:
○ The contract start date:
○ Volume of letters per month:
○ Total contract value:
○ What is the name(s) and position(s) of the key internal stakeholder(s) for this service:
○ What is the person(s) email and telephone number:
○ What would you like to see in this product that is currently not being delivered:
Speech Recognition
● Do you use Speech Recognition? If yes, could you please answer the following questions:
○ Name of the supplier & product?
○ How many user licences do you have?
○ What procurement method (if any) was used to obtain this system, i.e. what framework?
○ The contract start date?
○ The contract expiry date?
○ Total contract value?
○ Is the product integrated with PAS or EPR?
○ What is the name(s) and position(s) of the key internal stakeholder(s) for this service?
○ What is the person(s) email and telephone number?
○ What would you like to see in this product that is currently not being delivered?
Ambient AI Scribe
● Do you use AI-enabled Ambient Scribe? If yes, could you please answer the following questions:
○ Name of the supplier & product?
○ How many user licences do you have?
○ What procurement method (if any) was used to obtain this system, i.e. what framework?
○ The contract start date?
○ The contract expiry date?
○ Total contract value?
○ Is the product integrated with PAS or EPR?
○ What is the name(s) and position(s) of the key internal stakeholder(s) for this service?
○ What is the person(s) email and telephone number?
○ What would you like to see in this product that is currently not being delivered?
Video Consultation
● Do you use Video Consultation? If yes, could you please answer the following questions:
○ Name of the supplier & product?
○ How many user licences do you have?
○ What procurement method (if any) was used to obtain this system, i.e. what framework?
○ The contract start date?
○ The contract expiry date?
○ Total contract value?
○ Is the product integrated with PAS or EPR?
○ What is the name(s) and position(s) of the key internal stakeholder(s) for this service?
○ What is the person(s) email and telephone number?
○ What would you like to see in this product that is currently not being delivered?
○ How many user licences do you have?
○ What % of virtual/remote consultations are conducted using video vs telephone?
Health Information Systems
What supplier(s) do you use for the following?
● PAS (Patient Administration System)
● EPR (Electronic Patient Record)
● eDMS (Electronic Document Management System)
● RIS (Radiology Information System)
● LIMS (Laboratory Information Management System)
● e-Correspondence (e.g. Docman)
● Hybrid Mail (e.g. Synertec)
● Patient Portal

FOI 5287 –
• The total Trust expenditure on framework agencies for the provision of Registered General Nurses, Registered Mental Health Nurses, and Health Care Assistants from 1st January 2024 to 30th June 2024.
• The total Trust expenditure on off-framework agencies for the provision of Registered General Nurses, Registered Mental Health Nurses, and Health Care Assistants for the same period.
• The total Trust expenditure through the internal Trust bank from 1st January 2024 to 30th June 2024.
• The total number of Nursing and Health Care Assistant shifts booked during this period.
• The total number of Nursing and Health Care Assistant shifts booked above NHSE capped rates during this period.
• The number of agencies currently assigned to tier 1, tier 2, and tier 3 under Lot 1.

FOI 5288 – In the financial year 2023-24, how many requests for additional funding were received by SNEE ICB under the double lock system?
In the financial year 2023-24, how many requests for additional funding were received by SNEE ICB under the triple lock system?
Does SNEE ICB have a target timeframe to respond to requests for additional funding?
If so, what is that target time frame?
Based on the experience of your organisation, are you successful in meeting this target?

FOI 5289 –
Provided with a list of the organisations from which your ICB commissions the following services (adult’s and children’s):
Community services
• District Nursing
• Community Matrons
• 0-19 service
• School Nursing
• Health Visiting
• Community paediatrics
• Intermediate care
• Urgent community response
• Virtual wards
• Speech and language therapy
• Physiotherapy
• Podiatry
• MSK
• Occupational therapy
• Dietetics
• Children’s community nursing
• Community end of life care
• Community dental services
• Children’s community nursing
• Continence team
• Sexual health services
• Wheelchair services
• Reablement
Rehabilitation Mental health, learning disabilities and autism services
• Assertive outreach
• Forensic services
• Eating disorder services
• Perinatal mental health
• ADHD services
• ASD services
• Memory services
• Generic community mental health services
• Inpatient mental health services
• PICU
• Mother and baby inpatient mental health services
• Substance misuse and addition services

FOI 5290 – Directory of providers holding qualifying contracts that enables them to accept Right to Choose referrals for Autism assessments and ADHD assessments and treatment for both adults and children.
Adult Autism Assessments
• Name of Provider
• Whether the provider is NHS or Independent Sector
• Whether the payment mechanism is block or tariff
• Expiry Date of Contract
• Whether the contract has an option to extend
• Expiry date of the contract with the option to extend exercised
• A copy of the contract Particulars
Children and Young People’s Autism Assessments
• Name of Provider
• Whether the provider is NHS or Independent Sector
• Whether the payment mechanism is block or tariff
• Expiry Date of Contract
• Whether the contract has an option to extend
• Expiry date of the contract with the option to extend exercised
• A copy of the contract Particulars
Adult ADHD Assessments and Treatment
• Name of Provider
• Whether the provider is NHS or Independent Sector
• Whether the payment mechanism is block or tariff
• Expiry Date of Contract
• Whether the contract has an option to extend
• Expiry date of the contract with the option to extend exercised
• A copy of the contract Particulars
Children and Young People’s ADHD Assessment and Treatment
• Name of Provider
• Whether the provider is NHS or Independent Sector
• Whether the payment mechanism is block or tariff
• Expiry Date of Contract
• Whether the contract has an option to extend
• Expiry date of the contract with the option to extend exercised
• A copy of the contract Particulars

FOI 5291 – Lead responsibility for Contract Management (person, job title, department and contact details).
Does your organisation use Atamis for procurement?
Does your organisation use Atamis for contracting?
Does your organisation have a healthcare contracts register?
Are current healthcare contracts published (eg on your website)? Please provide a link.
What is the current mechanism for identifying contracts currently in place (eg hard copy paper, spreadsheet, specialist contract database)
If you use a software system please state which system you use.
If this is not an in-house system, please provide the contract start and end dates and value excluding VAT.
What is the total number of healthcare contracts your organisation holds? (This may include but not limited to: FTs, mental health, community, primary, healthcare grants etc).
How many contracts do you have for each of the following?
a. CHC
b. FT
c. GP
d. GP Federation
e. Independent Community Provider
f. Independent Sector Hospital
g. Local Authority
h. Optometry
i. Pharmacy
j. Dental
k. Other

FOI 5292 –
How do children of Compulsory school age in your area access vaccinations if the following applies:
a) They are not in school on the day vaccinations are occurring
b) The child receives their Education through EOTIS (s61 Children and Families Act)
c) The child is receiving education through a multitude of alternative provision
d) The Child is electively home educated.
How do children of Compulsory School age in your area access Speech and language therapists when:
a) They are enrolled and regularly attend school
b) The child receives their Education through EOTIS (s61 Children and Families Act)
c) The child is receiving education through a multitude of alternative provision
d) The Child is electively home educated.
How do children of Compulsory School age in your area access Occupational therapists when:
a) They are enrolled and regularly attend school
b) The child receives their Education through EOTIS (s61 Children and Families Act)
c) The child is receiving education through a multitude of alternative provision
d) The Child is electively home educated.

FOI 5209 –  mobile phones details:

1. Who is ICB’S current mobile phone provider?
2. How many mobile connections are there?
3. When is the contract up for renewal?
4. The name and email address of the primary contact for the contract?

FOI 5210 –

1. What is the amount spent on community services, by provider in 2023-24.
2. What is the planned spend on community services, by provider, in 2024-25.

FOI 5211 – Did Colchester General Hospital Laboratory use the American Urological
Association PSA guidelines when reporting PSA results in April 2009?
If so, does Colchester General Hospital Laboratory still use the American Urological
Association PSA guidelines for reporting PSA results?
If not, please advise what date this changed and which guidelines are now followed.
If Colchester General Hospital Laboratory did not use the American Urological
Association PSA guidelines when reporting PSA results in April 2009, what guidelines
did the Laboratory use at this time?

FOI 5212 – Questions related to provision and planning of rehabilitation services by ICB.

FOI 5213 – NHS Continuing Healthcare (NHS CHC) services question:

1. Who is responsible for managing CHC services within ICB? Please provide the job title/role of the officer(s) responsible, their name, and appropriate contact details.
2. Who is responsible for undertaking CHC assessments for ICB? Please provide the job title/role of the officer(s) responsible, their name, and appropriate contact details. If this function is outsourced, please confirm the name of the subcontractor(s).
3. Who is responsible for determining the eligibility for CHC services for ICB? Please provide the job title/role of the officer(s) responsible, their name, and appropriate contact details. If this function is outsourced, please confirm the name of the subcontractor(s).
4. How many people does the ICB currently fund CHC for?
4a. For the above, please provide a breakdown by age category, i.e. adult or child.
5. In the past 12 months, or the closest reporting period, what was the total expenditure on CHC?
5a. For the above, please provide a breakdown of this expenditure for each category/condition, e.g. palliative care, physical disability, learning disability.
5b. For the above, please provide a breakdown of this expenditure by age category, i.e. adult or child.

FOI 5214 – AI technoloy questions:

1. AI Technology Transcription/Dictation Consideration:
o Has the ICB considered implementing a specific AI technology transcription/dictation solution within its systems or for use by GP practices within the ICB?
o If so, at what stage is the consideration process (e.g., initial discussions, pilot program, full implementation)?
o Can you provide any relevant documents outlining the rationale for considering this AI technology (e.g., feasibility studies, risk assessments)?
3. AI Governance and Oversight:
o Does the ICB have a specific policy or framework for evaluating and approving the use of AI technologies within its systems or by GP practices?
o If so, please provide a copy of this policy or framework.
o In the absence of a specific AI policy, how does the ICB ensure the responsible and ethical implementation of AI tools?
4. Compliance and Governance Lead:
o Please provide the name and contact details of the lead for compliance and/or governance within the ICB responsible for the installation of new software for GP practices
5. IT Support:
o Please provide the name and contact details of the lead for IT support within the ICB responsible for the installation of new software for GP practices
6. IT and Compliance/Governance Services Provider (if applicable):
o If the ICB outsources IT or compliance/governance services, please provide the name and contact details of the company providing these services.
7. List of GP Practices: (please provide on excel)
o A comprehensive list of all GP practices within the ICB, broken down by borough.
o Please include the name and contact details of the lead GP for each practice.

FOI 5215 – Does ICB have Local Enhanced Services (LES) or Directed Enhanced Service (DES) in place for Primary Care related to wound care?
If Yes:
When was the LES/DES last reviewed/updated?
When is the LES/DES due to be reviewed/updated?
Does the LES/DES include postoperative wound management? Y/N
Does the LES/DES include traumatic wounds e.g. trauma and skin tears? Y/N
Does the LES/DES include complex wound care? Y/N If no:
who manages complex wound care for non-housebound patients?
Does the LES/DES include pressure ulcer prevention or pressure ulcer wound care? Y/N
Do you have any primary care led wound clinics?

FOI 5216 – Does ICB intend to renew contract with Docman for workflow services or is considering other providers? If the latter, will the selection be made through a tender process or a specific framework?

FOI 5217 – Does ICB holds the following data and where it is held; please provide the data as requested.
How adult (>18-years-old) Type 2 diabetes care is structured in the ICB including how primary care, community care and secondary care services interact and the roles / responsibilities they each take. 9. Please provide a list of each provider and service for all elective, consultant-led services for adult (>18) Type 2 diabetes that require a GP referral to access.
What is the service specification (whether standalone or not) for each service
What is the number of patients referred to each service in NHS Financial Year 2023-24 (e-RS data is acceptable)
What is the number of patients that started treatment in NHS Financial Year 2023-24.

FOI 5218 – How much money has the ICB and its predecessors (i.e. CCG) paid to management consultancies for the purposes of primary care strategies/projects, in each of the following years:

1. 2019/20
2. 2020/21
3. 2021/22
4. 2022/23
5. 2023/24
6. 2024/25

FOI 5219 – Please provide a list of GP surgeries within your ICS region that are using a Cloud-based
telephony system from a non-framework-approved supplier. (Advanced Telephony Better Purchasing Framework).

FOI 5220 – Request for data contained within the Primary Care Data Gathering, an excel sheet that can be downloaded from SHAPE by the ICB.

FOI 5221 – What is ICB’s Smart System Co-ordination Centre digital solution.

FOI 5222 – Request for a copy of NPM agreement the Trust has with their anti-embolism stocking (AES) supplier.

FOI 5223 –
1. How many UTI tests were performed in last 12 months at any location?
a. What is the cost of each dipstick test?
2. How many were sent to the lab for further testing?
a. How much is the cost per test for the lab?
3. What is the sample turnaround time back to the GP/Diagnostic Centers?
4. How many UTI appointments were attended over the most recent 12 month period?
5. How many of those appointments were DNA (Did Not Attend)?
6. How many patients were
a. 18 above/ under?
b. Age 65?
c. Male?
d. Female?
7. Who would perform the Test (GP/Nurse/ Banding Level?)
8. How many UTI Confirmed/ Non-Confirmed patients received antibiotics?
This will often include terms such as provision of an urgent care system dashboard or platform and resilience.
1. Who is your supplier?
2. If it is an in-house system, who is the lead?
3. If using an external supplier, how did the ICB procure the current supplier (eg name of framework & lot etc, or advertised tender, or not put out for procurement single contractor appointed).
4. What was the justification for the procurement route eg single supplier waiver / single contractor appointed?
5. Please provide who (person and job title) of the individual that had lead responsibility for the appointment of the supplier.
6. Who has lead responsibility for future provision of for the SCC?
7. What is the contract period (please provide start and end dates)?
8. What is the approximate value of the contract (set up and ongoing costs) please state gross amount if non-recoverable VAT.
9. What teams and roles are responsible for leading the decision of which Smart SCC digital solution to procure?

FOI 5224 –

• In your social services, what departments have access to a social budget to supports individuals
• What services fall under that Social Care Budget
• How many times does your Panel meet to determine budget in a month
• Who is the main contact for those services and what is their contact email address / telephone number
• How much funding is available through your Social Care budget
• What is the allocation of the Social care Budget to different services
• Do you have a separate commissioning Team for Private Healthcare Budgets
• What are the teams contact details
• Have you got a list of providers you share with families looking for support through their Private Healthcare Budgets
• How would an organisation get added to the Private Healthcare budgets provider list
• How much funding is currently available through PHB’s

FOI 5225 –

• In the ICB, what departments have access to the health care budget to supports individuals
• What services fall under that Health care budget
• How many times does the Panel meet to determine budget in a month
• Who is the main contact for those services and what is their contact email address / telephone number
• How much funding is available through the health care budget
• What is the allocation of the health care budget to different services
• Do you have a separate commissioning Team for Private Healthcare Budgets
• What are the teams contact details
• Have you got a list of providers you share with families looking for support through their Private Healthcare Budgets
• How would an organisation get added to the Private Healthcare budgets provider list
• How much funding is currently available through PHB’s.

FOI 5226 – What CQC registered providers has the ICB used for complex/homecare packages between the period of 1st January 2023 -30th March 2024.

FOI 5227 – When would the Suffolk and North East Essex ICB be able to re-procure for online triage tooling/demand and capacity tooling.

FOI 5228 – What is the up-to-date ARRS spend of PCNs for the 2023/24 Financial Year (April 23′-March 24′) & any 2024/25 claims.

FOI 5229 – Dynamic Support Register (DSR) for children and young people (CYP) within ICB.

FOI 5230 – Provision of virtual ward care within ICB. 

FOI 5231 – A complete list of the email addresses of all the GP surgeries in Suffolk and North East Essex.

FOI 5232 – Does the ICS have access to a Shared Care Record?

FOI 5233 – In the last year June 2023 till June 2024 how many people have requested copies of their medical records directly or via a subject access request?

FOI 5234 – The name and contact e-mail address of the person responsible for Women’s Health & does ICB fund a menopause specialist clinic in the area & does ICB fund menopause clinics in Primary Care.

FOI 5235 – Details regarding ICB AACC – Finance & Data Reporting & Service Delivery.

FOI 5236 – Has the ICB adopted NG28 guidance for use of CGM in the T2 population that NICE recommend? If yes, please can you provide the policy related to this?

FOI 5237 – What is the Treatment Pathway, Formal Strategy or Plan, Programs or Initiative for sleep and/or insomnia within ICS/ICB? Please provide detailed information for both acute and chronic insomnia, including any specific protocols or guidelines followed. How is data collected and who is responsible for it.

FOI 5238 – For East Suffolk And North Essex NHS Foundation Trust West Suffolk NHS Foundation Trust what is the record held of the number of days each of the following NHS Trusts were at Level 1,2,3 incident response level between June 2023 and May 2024 inclusive.

FOI 5239 –

• Is there an Out Of Hours service in your ICB area?
• What is the resident population of your ICB area?
• What is the length of your contract?
• What is the contract value? And is it paid annually?

FOI 5240 –

1. How many dentists provided NHS services in the ICB for each of the following years (2018, 2019, 2020, 2021, 2022, 2023, 2024)? Could you please ensure the data is separated by year?
2. How many dentists stopped providing NHS services in the integrated care board for each of the following years (2018, 2019, 2020, 2021, 2022, 2023, 2024)? Could you please ensure the data is separated by year?
3. Could you please provide me a list of all NHS dental practices within the ICB?
4. Could you please provide a breakdown of waiting times to visit a NHS dentist within the ICB for each of the following years (2018, 2019, 2020, 2021, 2022, 2023, 2024)? Could you please ensure the data is separated by year?
5. How much did patients spend on dental procedures from NHS dentists in the ICB for each of the following years (2018, 2019, 2020, 2021, 2022, 2023, 2024)? Could you please ensure the data is separated by year?

FOI 5241 –
• Is Suffolk and North East Essex ICS a participant in the new RM6281 Workforce Alliance framework?
• What are the timeline and process for the RM6281 framework to become operational?
• Who is the designated staff responsible for selecting and contracting suppliers for clinical temporary staff, including their email addresses and office phone numbers?

FOI 5242 – Information regarding ICB’s finance software system.

1. The name of the supplier who implemented your finance software system.
2. The installation date of your finance software system.
3. The contract expiration date for your current finance software system.
4. The total upfront installation and implementation costs for your finance system, including software, consultancy, training, and related expenses.
5. The total annual costs to run and maintain your finance system.
Please can you also break down your annual costs by:
o Software licensing fees
o Maintenance and support fees
o Hardware costs
o Consultancy
o Training
o Other recurring expenses (please specify) 6. Do you have any plans to switch to a different finance system or upgrade the current system?

FOI 5243 – In relation to all GP practices in the ICB; what are eating disorder in-patient and out-patient treatment centres; hospitals and pharmacies in your PCNs:

Name of organisation
Type of organisation (GP practice; eating disorder in-patient and out-patient treatment centre; hospital or pharmacy)
Address of organisation
Practice Manager’s name
Practice Manager’s email address (or main email if not available)
Practice Manager’s telephone number (or main number if not available).

FOI 5244 – Information regarding CAMHS Tier 4 beds and patients.

FOI 5245 – Has the ICB in the 12 months contracted with an independent provider to provide community diagnostics, including mobile diagnostic solutions?

FOI 5246 – For each sub-ICB location (using the latest boundaries), provide the number of young people aged 11 to 25 inclusive who presented in A&E or urgent care with a mental health diagnosis in calendar years 2017, 2019, 2021, and 2023? Additionally, split this data into two age groups: 11-18 and 19-25.
Please include diagnoses with the following ICD-10 codes in any diagnostic position:
• F20-29: Schizophrenia, schizotypal and delusional disorders
• F30-39: Mood disorders
• F40-49: Neurotic, stress-related and somatoform disorders
• F50-59: Behavioural syndromes associated with physiological disturbances and physical factors
• F60-69: Disorders of adult personality and behaviour
• F90-98: Behavioural and emotional disorders with onset usually occurring in childhood and adolescence
• F99: Unspecified mental disorder
• G47: Disorders of initiating and maintaining sleep [insomnias]
• Z91.5: Personal history of self-harm

FOI 5247 –

1. Does ICB currently fund prescription of semaglutide 2.4mg (Wegovy) within specialist weight management services?
2. Please name the specialist weight management services ICB commissions.
3. If you do not commission a specialist weight management service, please name any specialist weight management services that operate within your ICB geography that you are aware of and are not commissioned?
4. Are there any additional criteria used to restrict eligibility in your ICB for semaglutide 2.4 mg (Wegovy) outside of the recommendations in NICE TA875?
5. Since 8th March 2023, how many letters of complaint has your ICB received from patients who feel they should receive semaglutide 2.4 mg (Wegovy)?
6. If you do not currently fund semaglutide 2.4 mg (Wegovy), is the ICB working to implement this?
7. If you are looking to implement semaglutide 2.4 mg (Wegovy), is it projected to be funded by your ICB before April 2025?

FOI 5247 –
1. Does ICB currently fund prescription of semaglutide 2.4mg (Wegovy) within specialist weight management services?
2. Please name the specialist weight management services you commission.
3. If you do not commission a specialist weight management service, please name any specialist weight management services that operate within your ICB geography that you are aware of and are not commissioned?
4. Are there any additional criteria used to restrict eligibility in your ICB for semaglutide 2.4 mg (Wegovy) outside of the recommendations in NICE TA875?
5. Since 8th March 2023, how many letters of complaint has your ICB received from patients who feel they should receive semaglutide 2.4 mg (Wegovy)?
6. If you do not currently fund semaglutide 2.4 mg (Wegovy), is the ICB working to implement this?
7. If you are looking to implement semaglutide 2.4 mg (Wegovy), is it projected to be funded by your ICB before April 2025?

FOI 5248 – Cyber security in the NHS, and who assists the trust.

FOI 5249 – What is the NHS Trusts Bank Spend in 22/23 (April 2022- March 2023) for East of England Ambulance Service NHS Trust & East Suffolk and North Essex NHS Foundation Trust & West Suffolk NHS Foundation Trust.

FOI 5250 – Most recent diabetes/blood glucose testing formulary/guidance for the ICB.

FOI 5251 –
1.What is your overall ICB population?
2.What is your final budget for local enhanced/commissioned services that are open for GP practices outside of the national GP contract?
3.Please fill in the attached Excel document, listing every LES/LCS that you are commissioning for GP practices

FOI 5252 –
1) Does ICB use a tool for Surveys? (a survey tool would help to create the survey, design the questions, distribute the survey, drive responses, and build out reports and insights into the data)
2) If so, which supplier do you use for this tool?
3) How much do you spend annually on a Survey Tool?
4) Which month & year does your contract with your supplier end?
5) Who is the budget holder for this contract?

FOI 5253 –
1. Please confirm how many Decision support tool assessments were undertaken in 2021, in 2022 and finally in 2023.
2. Please confirm how many awards to provide continuing healthcare funding were made following decision support tool assessments in 2021, 2022 and 2023.
3. Please confirm how many cases requested local ICB appeals (Local Review Meetings / local appeal) of the negative decision of the decision support tool assessment for continuing healthcare in 2021, 2022 and 2023.
4. How many individuals were successfully awarded continuing healthcare funding following an local ICB appeals (Local Review Meetings / local appeal) in 2021, 2022, 2023.

FOI 5254 –
•Do you commission a Tier 3 specialist weight management service? Is it located within your ICS catchment? If not, where are people within your ICS requiring Tier 3 weight management services typically referred?
•If you commission a tier 3 service, is it currently accepting new referrals? And if it is not accepting new referrals, when did this come into effect?
•Do you fund bariatric surgery for people living in your ICS?
•Please list all the current criteria that are used within your ICS for funding decisions regarding bariatric surgery -For example, but not limited to, BMI cut-offs, type 2 diabetes status, time in Tier 3 weight management service, requirement for preoperative weight loss, comorbidities etc.
•Is there a commissioned/designated bariatric surgery service located within your ICS catchment? If not, where are people requiring bariatric surgery within your ICS typically referred?
•Is there a Wegovy pilot site located within your ICS? [https://www.gov.uk/government/news/new-drugs-pilot-to-tackle-obesity-and-cut-nhs-waiting-lists].

FOI 5255 – Are data systems between primary, community, and secondary care integrated, and if not – are there plans to integrate them? Is there a baseline mapping of digital infrastructure in place.

FOI 5256 – Medicines Optimisation team within ICB.
•Names and Positions: A list of current members of the Medicines Optimisation team, along with their respective roles and titles.
•Contact Information: The official email addresses and/or telephone numbers for each member of the team.
•Organisational Structure: Any available documentation outlining the structure of the Medicines Optimisation team, including how it integrates with other departments within the ICB.

FOI 5258 – What software you are currently using to facilitate BACS payments & what is the date of the renewal for this contract? What is the worth of the contract.

FOI 5259 – Which fertility clinics NHS-funded patients in your ICB are able to use for their fertility treatment? In addition, do patients get a choice in where they go for treatment?

FOI 5171 –  1.Which hospital trusts within your ICS perform antenatal screening, including the 20 week foetal anomaly scan?
2.When congenital heart defects are not identified during screening at the 20 week foetal anomaly scan;
a)Which hospital trusts within your ICS do not retain the foetal cardiac views?
b)For how long has each hospital trust within your ICS not retained the foetal cardiac views?
3.When congenital heart defects are not identified during screening at the 20 week foetal anomaly scan;
a)Which hospitals trusts within your ICS do retain the foetal cardiac views?
b)For how long has each hospital trust within your ICS retained the foetal cardiac views?
c)Concerning the trusts which do currently retain cardiac views when congenital heart defects are not identified, please clarify whether these trusts retain still images or video clips or both.

FOI 5172 – Does the ICB
1) use a social media management platform?
2) If so, what tools do you use?
3) What is the annual spend on a Social media management tool?
4) What dates does your contract with your current supplier end ( month & year)?
5) Is social listening / media monitoring platform used?
6) If so, what tools do you use?
7) What is the annual spend on a social listening / media monitoring tool?
8) What dates does the contract with current supplier end ( month & year)?
9) Who is the senior person responsible for managing these contracts?

FOI 5173 – What are the latest figures (2023-2024) for people suffering from long term health conditions in Suffolk and East Essex and which conditions are the most prevalent? And who are the key providers of care for this group?

FOI 5174 – Ophthalmology – What tariffs related to the treatment of patients with Wet age-related macular degeneration does ICB have.
a. Do you use national tariffs for outpatient appointments, scans, and for treatments. If so, which ones do you use? Please provide HRG codes where possible.
b. If locally negotiated tariffs are used, please provide details of these. If ‘bundled’ (e.g. include treatments/scans etc), please advise on what is included in the cost. If ‘unbundled’ (e.g. each element is costed separately), please advise on the locally agreed price for each element.

FOI 5175 – What are the targets related to Children and Young People’s (CYP) mental health services.
1. What was the ICB’s target for the number of CYP accessing support through NHS funded community mental health services in 2023/24, as aligned with the MHS95 metric: Number of CYP aged under 18 supported through NHS funded mental health with at least one contact (12 month rolling)
2. Was this achieved? Please provide the total number of CYP accessing support through NHS funded community mental health services in 2023/24 as aligned with the MHS95 metric above.
3. Has an indicative target for CYP accessing support through NHS funded community mental health services (MHS95 or alternative) been set for 2024/25? Please could you advise on what this target is?

FOI 5176 – Does ICB currently have a community tele-dermatology provider and if it is not the acute trust, who are the providers covering ICS?

FOI 5177 – Details regarding ringfenced suicide prevention funding allocated to Suffolk and North East Essex ICB/ICS for three years via the NHS Long Term Plan.

FOI 5178 – Please list numbers of people 18-65 plus years with whom your agencies have/had contact with, with the following ICD 10 and ICD11 diagnostic codes irrespective of where they are situated within the spectrum of individuals codes. Provide the data for the period between Jan 1st 2019 and March 31st 2024.
The 1C1 codes are from the ICD11 – if you have not yet implemented it, state so otherwise provide the data for the ICD10 codes listed.
A69.2, A69.9, 6D85.Y, 9B66.1, 8A45.OY,
1C1G.Z, 1C1G.11, 1C1G.12, 1C1G.Y, 1C1G.0, 1C1G.1Z, 1C1G.13, 1C1G.10, 1C1G.1Y, 1C1G14
Provide the numbers of people 0-18 with the following codes between the same period:
A69.2, A69.9, G51, G58.7, G58.9, G03.9, MO6.4, L90.4.

FOI 5179 – Does ICB collect or hold data on the following:
a. The number of assessments and the number of individuals eligible for standard and fast-track NHS continuing healthcare by age (e.g. date of birth)
b. The number of assessments and the number of individuals eligible for standard and fast-track NHS continuing healthcare by gender
c. The number of assessments and the number of individuals eligible for standard and fast-track NHS continuing healthcare by ethnicity
d. The number of assessments and the number of individuals eligible for standard and fast-track NHS continuing healthcare by patient diagnosis type.

FOI 5180 – The total amount the ICB (or, where applicable and possible, its predecessor CCGs) has spent on commissioning palliative and end-of-life care in each of the following financial years: 2019-20, 2020-21, 2021-22, 2022-23, 2023-24.

FOI 5181 –

1. How many GP appointments were taken where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weight loss drugs were given as a reason for the appointment in every year between 2018 and 2023. Please give a figure for each year.
2. How many A&E attendances were there where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weightloss drugs were given as a reason for the attending in every year between 2018 and 2023. Please give a figure for each year.
3. How many deaths were recorded where an overdose of either Saxenda, ozempic or wegovy (medical names Liraglutide and semaglutide) weight loss drugs were given as a reason in every year between 2018 and 2023. Please give a figure for each year.

FOI 5182 – What are the ICB’s arrangements to enable providers to express an interest in providing services subject to Patient Choice and PSR Direct Award Process B.
What is the ICB’s accreditation process for providers of services subject to Patient Choice and PSR Direct Award Process B.
What is the name of the person responsible for Patient Choice at the ICB.

FOI 5183 –

1. What are the names of each PCN in the ICB area and which GP practices are members of which PCN
2. The name of the Clinical Director of the PCN and their email address
3. The name of the Health Inequalities Lead of the PCN and their email address (if applicable).

FOI 5184 –

1.Does ICB currently have a contract or Framework in place to commission packages of care for Adults living with Learning Disability, Autism and/or Physical Disabilities. If Yes: When does this expire? What is the name/title of the Contract, email address, phone number? If No: How do you commission the above package for Adults living with Learning Disability, Autism and/or Physical Disabilities.
2. Is an online platform/portal to publish referrals used? If yes: How to register on the portal? If no: How to access information about new package of care opportunities?
3. Do you have a set rate for packages of care for Adults, if Yes what is the current rate for 2024? Please list the different tiers.
4. What is the correct phone number or email address for the team who commission packages of care for Adults living with Learning Disability, Autism and/or Physical Disabilities.
5. Who is responsible for Commissioning please advise of their name, email address and telephone number.

FOI 5185 –

1. What is the current medicines optimisation (or equivalent) team structure?
2. What are the current medicines optimisation (or equivalent) team roles and functions?
3. Is there any further staff reorganisation planned in the financial year 2024/25 that may change your current medicines optimisation (or equivalent) team structure?

FOI 5186 –

1. Is the ICB involved in the arrangement of clinical insourcing solutions to support the waiting list recovery in NHS trust?
2. If yes, can the ICB confirm which insourcing services solutions it has recently be involved in procuring and how these services were procured?
3. Please provide specific job title/department information as who is responsible for procurement of insourcing services.

FOI 5187 – Is the ICS’s stance using 3rd party insourcing to help recover backlogs?
If ‘no’ is the ICS open to using 3rd party insourcing to help recover backlogs?
Is there one particular procurement framework used by the ICS to procure insourcing companies?

FOI 5189 –

1: Does NHS Suffolk and North East Essex ICB have any local guidelines or polices for the treatment of obesity?
2: Does NHS Suffolk and North East Essex ICB have referral pathways for Tier 3 or Tier 4 weight management services?

FOI 5190 – Structure charts for the digital team, including all the levels of management (with names and email addresses).

FOI 5191 – When is the Docman contract due to come to an end if this is applicable to ICB.

FOI 5192 – Request for the most current email address (either for ‘front of house’ or a Practice Manager) held for all NHS GP surgeries.

FOI 5193 –

1.What is SNEE financial envelope/allocations agreed/committed to supporting the Virtual Wards programme for the 2024/25 financial year?
2.Confirm if any of last year’s £696K funding for innovative medical technology as part of the Health Technology Adoption and Accelerator Fund was spent to support virtual wards?
If yes, please could you confirm
a. What technology
b. The Value (£) of the investment
3. Confirm, out of the currently reported 161 virtual ward beds capacity, how many/or what percentage is supported by remote patient monitoring?

FOI 5194 – What was the amount spent on community services, by provider in 2023-24 and what is the planned spend on community services, by provider, in 2024-25.

FOI 5198 – Copy of “ICB guidelines on off label prescribing”.

FOI 5199 –

1. When is the ICB next going through an audit of the national fraud initiative?
2. What current procedures are there in place such as confirmation of payee against fraud?
3. What is current confirmation of payee software incumbent product & the renewal date of the contract.

FOI 5201 –
How many Primary Care Networks or GP Federations has the ICB supported financially with their premises costs?
What are the names of these PCNs / Federations?
Were the contributions capital (e.g grant for purchase / redevelopment) or revenue ( e.g rental reimbursement or contribution)?
Under what contractual mechanism were any arrangements made?

FOI 5202 –

Q1. Can you please list the number of devices deployed by your organisation for the following?
Device Type
Desktop PCs
Laptops
Mobile Phones
Printers
Multi Functional Devices (MFDs)
Tablets
Physical Servers
Storage Devices (for example: NAS, SAN)
Networking Infrastructure (for example: Switches, Routers, Interfaces, Wireless Access Points)
Security Infrastructure (for example: Firewalls, Intrusion Detection Systems (IDS), Virus Monitoring Tools)
Q2. Does your organisation plan to procure any of the below enterprise applications or software, if yes, please provide information in the below format.
Q3. Do you have any plans to procure End user devices (desktop/laptop/tablet/mobile phones etc)? if yes, please provide information in the below format.
Desktops
Laptops
Mobile Phones
Tablets and Others (Please specify, if Others)
Q4. Do you have any plans to procure below services/softwares? if yes, please provide information in the below format.
Artificial Intelligence (AI)
Cyber Security.

FOI 5203 –

• The estimated number of children currently living with heart defects and tube feeding issues.
• The number of children with these conditions who have received at-home support services in the last five years (broken down by year).
• The number of children with these conditions currently awaiting at-home support services (broken down by year for the last five years).
• The number of children with these conditions who have requested at-home support services in the last five years (broken down by year).
• The number of children with these conditions who are currently in receipt of at-home support services (broken down by year for the last five years).
• The estimated number of children with these conditions who are eligible for at-home support services (broken down by year for the last five years).
• Additionally, I would appreciate any insights into the challenges associated with finding or extrapolating this data, such as variations in assessments/criteria or inconsistencies in data tagging of patients.

FOI 5208 – Information related to Personal Health Budgets (Direct Payments) that ICB is responsible for under NHS SNEE ICB.

FOI 5133 –

• What is this ICB’s budget for physical rehabilitation services for FY2023/24.
• How much has been spent on physical rehabilitation services each year since 2014 to date.
• How is this spending broken down by service provisions.
• What proportion of this is inpatient vs outpatient.
• How many patients accessed rehabilitation services, or how many appointments were fulfilled, each year from 2014 to date.

FOI 5134 – 1. Within the ICS/ICB, which secondary/tertiary care centres are recognised as providing expert advice on the management of hypertension?
Please state the names of the Departments or Units and the lead specialists for the services including their institutional addresses, and whether these services are commissioned by the individual ICB/S’s.
2. Within the ICS/ICB, to whom are patients referred who have had a past history of hypertension in pregnancy which is still elevated 1 year after delivery?
Please state the names of the Departments or Units and the lead specialists for the services including their institutional addresses.
3. Does the ICS/ICB provide information to GPs about the availability of local secondary/care specialist hypertension services and who should be referred?
4. Does the ICS/ICB consider that the provision of secondary care specialist hypertension services is adequate for the population served?

FOI 5135 – Contact details for SDE commissioning for the ICB for Type 1 & 2 diabetes education.

FOI 5136 – 1. How many current employees are at the ICB?
2. Can you please break these down by job role?
3. How many redundancy consultations have taken place since your ICB was set up in July 2022 until the end of April 2024? Please break this down by job role.
4. And of those, how many roles have been made redundant in the same period (July 2022 – end of April 2024)? Please break this down by job role.
5. How many roles were made redundant in the 2023/24 financial year? Please break this down by job role.
6. Are you currently running a voluntary redundancy scheme? If so, when did this start? And when do you expect it to end?
7. If you ran a voluntary redundancy scheme in the last financial year (2023/24) but it has already ended, please state what date this ran from and until.
8. If you have a voluntary redundancy scheme, do you/did you have a target for the number of redundancies you are aiming for?
9. If you have a voluntary redundancy scheme, how many redundancies have been confirmed through this so far? And what job roles are these?
10. What has been the cost savings from making the redundancies between July 2022 and end of April 2024? Please break this down into voluntary and mandatory redundancies.
11. What has been the cost savings from making the redundancies in the last financial year (2023/24)? Please break this down by voluntary and mandatory redundancies.
12. What has been the expenditure from making the redundancies between July 2022 and end of April 2024? Please break this down for voluntary redundancies and mandatory redundancies.
13. What has the expenditure been from making the redundancies in the last financial year (2023/24)? Please break this down for voluntary redundancies and mandatory redundancies.
14. How many hires have there been between July 2022 and end of April 2024?
15. How many hires have there been in the last financial year (2023/34)?
16. How many resignations have there been between July 2022 and end of April 2024?
17. How many resignations have there been in the last financial year (2023/24)?
18. How many terminations of contracts have there been between July 2022 and end of April 2024?
19. How many terminations of contracts were there in the last financial year (2023/24)?
20. How many employees are currently on secondment to other parts of the NHS?

FOI 5137 – Missing file for ICB’s Spend/Transparency data – February 2024.

FOI 5138 – What is the name of the IT system that is used to support your regional Shared Care Record?

FOI 5139 –

• Since December 2023, which Nurses Shifts has the Trust struggled to fill ? Please consider the following Specialities for this question : A&E Nurses, NICU,ICU, Midwives, Paediatric Nurses & General Nurses?
• Do approved Framework agencies approve or confirm Shifts directly with the matron Nurses or any senior nurses directly in the wards with the agencies ( Within any of the wards)? If, yes which wards book Nurses directly with the agencies & please provide these Nurses Full names?
• When does Temporary Staffing get approval for “Escalated rates” for Ad-hoc Shifts ? Please provide time scale leading up to the Shift date
• When does Temporary Staffing get approval for “Escalated rates” for Long term Agency Nurse Bookings? Please provide time scale leading up to the booking?
• Who in the trust has the authority to approve the use of Escalated rates or break glass rate for the Approval Framework agencies, Please provide Full Name & Email address ?
• Please provide names of those agencies that are “breaching NHSI Rates” by being allowed to book Nurses & Midwives not within the NHSI capped rates ?
• If an Approved framework agency can demonstrate their ability to provide Nurses & meet all the requirement with the possibility of using the alternative route of escalated or Break Glass rates , would Temporary staffing add that agency to their Tier 1 Suppliers list?
• Who is the head of Procurement responsible for approving “Approved Framework agencies” to join their Tier 1 Suppliers list to provide Nurses & Midwifes ? Please provide Full name & contact address email.

FOI 5141 – Is Barnardos required, as per their contract, to support the ICB with any FOIs?

FOI 5142 – Information regarding funding schemes for cancer-patients’ treatments and monitoring.
a. Does the trust provide funding for point-of-care home blood monitoring devices for people with cancer who are receiving systemic anticancer therapy?
b. If not, is it because the pharmaceutical company already funds it?
ii. If yes, out of which budget does it come out from? (please elaborate)
c. Furthermore, if these funding schemes do not currently exist at your trust and are not funded by pharmaceutical companies, are there plans to fund such initiatives in the future?
i. If yes, please give some examples of some of the funding initiatives. Examples of some of these funding pots include but are not limited to, the virtual wards fund, the digital fund, and the Improved Better Care Fund (iBCF)?

FOI 5143 –

a)Do you currently use virtual wards? (Y/N)
b)If yes,
i. Can you please specify how many virtual wards beds you have and the provider by specialty (Cancer care, respiratory care, cardiology care, diabetes care, stroke care, renal care, pre/post-operative care services, other)?
ii. How many patients have been admitted in virtual wards, per specialty, for the Financial Years (FY) 2018, 2019, 2020, 2021, 2022, 2023 and 2024YTD (Year to Date)?
iii. What are the values of the contracts you have in place split by specialty and provider?
iv. What are the durations of the contracts you have in place split by specialty and provider?
c)If no,
i. If you are not currently using virtual wards, are you planning on using them in the future?
ii. For which specialties are you planning on using them?
iii.When would you start?

FOI 5144 –

1. The name of the Assistant Director of Finance (or equivalent) for each place within the ICB
2. Their job title
3. Their email address
4. Their contact phone number
5. The name of the ICB’s Chair of the Finance Committee
6. Their email address
7. Their contact phone number.

FOI 5145 – In which localities / places do you currently commission an NHS Adult audiology service within your ICB geography?

FOI 5146 –
1.Please confirm if your ICB operates on a CHC framework with a single rate, and confirm the rate and any criteria relevant to this rate, and confirm the uplift applied to this framework rate for the period 2024/25. The ICB does not operate a framework with a single rate.
Note: If your ICB offered a range of rates, please outline the MEAN / MEDIAN / LOWEST / HIGHEST uplifts offered to Registered Older Persons Nursing Homes (If this rate differs by place, please add additional rows to reflect each place):
2. If your ICB places CHC residents outside of a CHC framework with a single rate, please confirm the rates and any criteria relevant to this rate, and confirm the uplift applied to this rate for the period 2024/25.
Note: If your ICB offered a range of rates, please outline the MEAN / MEDIAN / LOWEST / HIGHEST uplifts offered to Registered Older Persons Nursing Homes (If this rate differs by place, please add additional rows to reflect each place): N/A
3. Please provide a copy of any letter or letters sent to care providers communicating CHC uplifts made by your ICB.
4. As of 31 March 2024, how many individuals were your ICB funding for CHC in Registered Older Persons Nursing Homes?
5. Regarding the NHSE Payment Scheme Principle that the ICB’s approach must:
‘promote transparency and good data quality to improve accountability and encourage the sharing of best practice’
6. Regarding the NHSE Payment Scheme Principle that the ICB’s approach must:
‘engage constructively with each other when trying to agree payment approaches’
7. Please provide the appropriate named contact details (Including: title, email address, phone number and address ) for the following topics:
A. Inflationary Uplifts contracts.
B. Fee Reviews (For instances of a resident’s change in need)
C. Commissioning chc@snee@nhs.uk
D. Payment and Invoice Queries (outside of SBS)
E. Development of processes for ICB’s approach to future uplifts.

FOI 5147 – Please provide the appropriate contact details for continence assessments and funding decisions/applications.

FOI 5148 – Within the Suffolk and North East Essex ICB could you please advise who is responsible within their job roles for:-
Commissioning
Urgent and Emergency Care
Innovation
Community Services
Community Transformation
Elective Recovery
Integrated Care
Integrated Discharge
Strategic Programme Delivery
Chief Operation Officer and Director of Operations.

FOI 5149 – Does ICB provides these services:
a. In-house (i.e. delivered in your NHS Acute / Community Trusts or provided by another NHS organisation)
b. Outsources (i.e. delivered by an independent provider in their care setting)
c. Insources (i.e. delivered by an independent provider in your care setting)
Additionally, please provide the following data for your ICB and for each financial year 2018/19, 2019/20, 2020/21, 2021/22, 2022/23, and 2023/24:
Hearing assessments
1. How many patients had a hearing assessment within the following settings and what was the total spending in £ on treating these patients (where possible please could you give the data per independent provider contracted):
a. In-house
b. Outsourced
c. Insourced
Hearing aid fittings
1. How many patients had a hearing aid fitting assessment within the following settings and what was the total spending in £ on treating these patients (where possible please could you give the data per independent provider contracted):
a. In-house
b. Outsourced
c. Insourced
Hearing aid aftercare
1. How many patients had hearing aid aftercare performed within the following settings and what was the total spending in £ on treating these patients (where possible please could you give the data per independent provider contracted):
a. In-house
b. Outsourced
c. Insourced
Hearing aid devices
1. How many hearing aid devices were delivered to patients within the following settings and what was the total spend £ on hearing aid devices for these patients in (where possible please could you give the data per independent provider contracted):
a. In-house
b. Outsourced
c. Insourced
Other
1. Could you please provide a copy of the service specification given to all bidders for when the contract for hearing aid services was last advertised?
If any of the specific splits are not available, please provide total figures for the system and specify which main splits are recorded by your ICB (in-house / independent sector).

FOI 5150 – Dentistry in the ICS:

1. The number of people on waiting lists to register for an NHS dentist in the ICS.
2. The current average waiting times for patients on the waiting list to register for an NHS dentist in the ICS.
3. The above information; but specified for under 18s.
4. Any targets set by the ICS for maximum waiting times to register for an NHS dentist.
5. The steps being taken by the ICS – if relevant – to manage and reduce waiting list times to access NHS dentistry.

FOI 5151 – How many General Ophthalmic Services sight tests have been performed within the ICB each year over the past six years?
Each year, over the past six years, what was the estimated budget for spending on GOS within the ICB? What was the actual spend for each year?

FOI 5152 – Up-to-date list of the dental practices within your ICB with NHS patients currently in their records – i.e. practices not listed as providing ‘private only’ dental care
– A breakdown of the dental practices within your ICB currently:
1. Accepting adults 18 or over as new NHS patients.
2. Accepting children 17 or under as new NHS patients.
3. Accepting new NHS patients only for specialist dental care on referral.
4. Not accepting any new NHS patients, and for how long this has been the case.
– The average time adult NHS patients currently on a waiting list have been waiting to be accepted as a patient (the average across your ICB)
– The date as of which the above information is accurate.

FOI 5153 – How many patients were diagnosed with each of the following between April 2022 – April 2023 & then April 2023 – April 2024 in paediatrics and then in adult gastroenterology:

Gastroparesis
Chrons
Functional bowel disorder

How many patients between April 2022 and April 2024 with a diagnosis of functional bowel had a test for scintography for paediatrics and in gastroenterology adult.

How many of those diagnosed gastroparesis between April 2022- April 2023 and April 2023- April 2024 received the following treatment –
A feeding tube
Metoclopramide
Botox injections
gastro-electrical stimulation
Bowel removal
State the above for a diagnosis of function bowel

Advise the current waitlist times for the following
Urgent paediatric gastroenterology-
Routine paediatric gastroenterology-
Urgent adult gastroenterology
Routine adult gastroenterology

State if Colchester offers adults or children gastro electrical stimulation? And if it doesn’t if it refers either group for that treatment to other NHS hospitals and if so which hospital and how many children, adults were referred between April 2023 – April 2024 ?
State if Colchester offers Botox injections for bowel treatment children , adults and if not again do they refer to other hospitals for that treatment, if so which hospital and how many adults, children were referred for that treatment between April 2023-April 2024?

FOI 5154 – Does your ICB commission Tier 3 weight management service and if yes what is the spend in 2023/24 and which companies are commissioned to deliver it.

FOI 5155 –

Does ICB commission any of the following services to provide mental health support to CYP? For each service please provide Name of the service, Provider, Contract length, Contract value, Commissioned capacity (e.g. how many CYP it seeks to support per year), Numbers of CYP supported in the last year, Whether the service covers the whole of your ICB/LA area, or only part of the population, Opening hours:

a. Mental Health Support Hubs
b. Early Support Hubs
c. Digital mental health services
d. CAMHS
e. Services provided by the voluntary and community sector (VCSE)
f. Other (please specify)

For each commissioned service, please provide a copy of the service specification and referral criteria
Contact details for the person(s) responsible for the commissioning of mental health services in your organisation.

FOI 5156 –

1. Who is responsible for the delivery of the PHB targets and what are their contact details (name, email and phone number)?
2. Who is responsible for the delivery of the Continuing Health Care programme and what are their contact details (name, email and phone number)?
3. Who is the Personalised Care or Personalisation Lead/Personalised Care Operations Lead at the ICB and what are their contact details ((name, email and phone number)?
4. Who is the Integrated Care Lead at the ICB and what are their contact details (name, email and phone number)?
5. Who is responsible for the digital transformation within the ICB and what are their contact details (name, email and phone number)?
6. Who is the current Director of Finance within the ICB and what are their contact details (name, email and phone number)?
7. How many people, including children, in your ICB have been awarded a Continuing Health Care budget in the most recent financial year and how many of these have taken up a PHB?

FOI 5158 – Email address of commissioners for children’s and adult’s ASD and ADHD services.

FOI 5160 – What family support contracts/services do you currently commission or deliver in house (including early intervention, prevention and edge of care)?
• If commissioned, how was the contract commissioned? Please confirm if it was direct award or via a formal procurement process.
• Please can you confirm the supplier/provider of each of these family support services/contracts?
• Please can you confirm the annual and total contract values of each of these contracts/services?
• Please can you confirm the start date & duration of each of these contracts?
• Could you please provide a copy of the service/product specification given to all bidders for when these contracts were last advertised?
• Within these services, do you use a keyworker model for delivery?
• Please can you confirm if there is an extension clause in each of these contracts and, if so, the duration of the extension?
• Has a decision been made yet on whether each of these contracts is being either extended, direct awarded or recommissioned? And if so what is the decision?
• Who is the senior officer (outside of procurement) responsible for each of these contracts?
• Are there any planned market engagement events for each of these contracts if they are being recommissioned?
• Are there any new family support contracts you intend to commission in the next 36 months that have already been confirmed/given permission to proceed?

FOI 5161 –

1. The number of patients provided with wheelchair services in your ICB.
2. The number of these patients that waited (a) 18 weeks, (b) 12 months, and (c) 2 years to access wheelchair services.
3. The longest (a) low need, (b) medium need, (c) high need, and (d) specialist need patient waited to access wheelchair services.

FOI 5162 – Does ICB currently have a contractual agreement in place for supply of services from Kooth Digital Health Limited, Tellmi (also known as MeeToo Education Ltd), Togetheral, Wysa Ltd,Cerebral Medical Limited, Silver Cloud. When is that agreement due to end?

FOI 5164 – What was overall 23/24, 22/23, 21/22 spend for interpretation and translation services?

FOI 5165 – How many maternity units your ICB has closed since 2020.

FOI 5166 –

• Do you intend to go out to procurement for any of the following service in the next 3 years? If you are what are the likely timescales for each service and who are the current providers for the below services.
o Community Persistent Pain service
o Community MSK and Physiotherapy service
o Community Rheumatology service
o Community Women’s health services

• Has the ICB appointed an ICB MSK lead? If so please provide their name and contact details.
• Has the ICB appointed an ICB Women’s Health lead? If so, please provide their name and contact details.

FOI 5167 – Epidemiology of psoriasis including local data.

FOI 5169 – What rules does ICB have around breast reduction. Are they NHS funded (free to patients)? Are there set criteria that have to be met to be eligible? Are there weight restrictions? Where would they be offered? Would patients have to go via GP or can self refer? How long is the waiting period, from referral to procedure?

FOI 5170 – How is the agency/ bank work policy run at ESNEFT.

5170 – What is the agency/ bank work policy at ESNEFT.

FOI 5090 – MSK service in ICB Region.

• How is the service delivered in your region? Ie: do you have a prime contract holder? Is it a collaborative provider? Do you have multiple provider contracts?
• What model do you plan to use moving forwards (ie: prime provider, collaborative…)?
• Who is the prime contract holder for your region?
• Who are the other MSK contract holders in your region?
• What is the financial envelope for each MSK contract in your region? Please specify the time period this covers.
• Is community MSK split out from the rest of MSK services?
• What are your MSK goals for RTT, GURFT and FFT?
• How are your MSK providers performing against RTT, GURFT and FTT?
• What are your MKS goals for reported patient outcome measures?
• How are your MSK providers performing against reported patient outcome measures?
• What is the length of your current MSK contract(s) and when is it(they) up for renewal?
• What are your priorities for MSK in the next 3 years?

FOI 5091 –

1. Which NHS trusts provide CAMHS?
2. Which CAMHS services are offered? Please list these services.
3. Do you operate a 0-25 service?
4. Can young people self-refer to CAMHS?
5. Which of the following non-specialist publicly-funded services for young people’s mental health (a) currently exist and/or (b) used to exist within the last decade (please indicate if they currently exist, and if they used to exist if you hold this data):
a. Social prescribing
b. Bereavement services
c. Peer support
d. Mental Health Support Teams
e. School counsellors, mentors, or pastoral or key support workers
f. Educational psychologists
g. Youth groups
h. Wellbeing cafes or mental health drop-in services
i. Youth information, advice and counselling services (YIACS) / early support hubs
j. Advice line for mental health issues
k. Targeted service(s) for LGBTQ+ young people
l. Targeted service(s) for young people from minority ethnic / racialised communities
m. Targeted service(s) for other underserved groups (please list here)
n. Targeted service(s) for young people on waiting lists for access to NHS mental health services (formerly tier 3)
o. Art or music therapy
p. Online support service / app
q. Occupational therapy
r. Any other service (please list here)
6. Do any of the following exist in your area (please answer yes or no and elaborate if necessary):
a. A CAMHS or young people’s mental health partnership board?
b. A designated individual or team who coordinates partnership working across services for children and families / settings?
c. Data-sharing infrastructure to share data across services, for example, schools, social care, youth justice, special educational needs teams, etc.?
d. Evaluation of young people’s outcomes following engagement with services?
e. A young people’s advisory group or official mechanism for young people to feed into service design and improvement?
7. Is there a single point of access for young people with a mental health concern? Please answer yes or no and elaborate if necessary.
8. Do you operate a ‘no wrong door’ approach? Please answer yes or no and elaborate if necessary.
9. Do young people have to be referred to access a mental health support service? Please answer yes or no and elaborate if necessary.
10. Are there specific services or approaches to ensure under-served groups of young people can access support e.g. young people from minority ethnic / racialised backgrounds, LGBTQ+ young people, etc.? Please answer yes or no and elaborate if necessary.
11. Do you have a publicly available up-to-date list or directory of voluntary, community and social enterprise (VCSE) sector young people’s mental health services? Please answer yes or no and elaborate if necessary.
12. Do you involve the VCSE sector in any of the following?
a. Planning / designing services.
b. As delivery partners – e.g. young people are referred to services offered by the VCSE sector.

FOI 5092 – Memory assessment services in SNEE ICB Region.
•Is memory/dementia assessment covered separately to wider dementia services, or is it covered under the same contract?
•How is the service delivered in your region? Ie: do you have a prime contract holder? Is it a collaborative provider? Do you have multiple provider contracts?
•What model do you plan to use moving forwards (ie: prime provider, collaborative…)?
•Who is the prime contract holder for your region?
•Who are the other contract holders in your region?
•What is the financial envelope for each contract in your region? Please specify the time period this covers.
•What are your main KPIs for memory assessment in your region?
•How are your memory assessment providers performing against these KPIs
•What is the length of your current memory assessment contract(s) and when is it(they) up for renewal?
•What are your priorities for memory assessment in the next 3 years?

FOI 5095 – Flexible Pool solutions operated by ICBs across England.
1. Kindly provide the names of supplier(s) contracted for flexible pool solutions by the ICB.
2. If the provision and/or funding responsibility has been delegated to other organisations, please provide the names of these entities and the suppliers they have contracted with.
3. Identify the team or individual responsible for procuring the supplier(s) mentioned in question 1.
4. Please disclose the annual payments made or scheduled to be made to each provider mentioned in questions 1 and 2 for the financial years ending on 31 March 2024, and 2025.
5. State the contract end dates for any existing contracts with each provider noted in questions 1 and 2.
6. With regards to the platforms provided by suppliers identified in questions 1 and 2, provide the monthly count of sessions advertised by GP practices and the number of those sessions successfully filled by locum GPs. Organize this information by geographical area (excluding data for extended access services) for the 6-month period ending on 31 July 2023. Additionally, include the count of locum GPs who have filled shifts during the same 6-month period.

FOI 5096 – ICB’s guideline on dyspepsia management in primary care
If you do not have an ICB guideline on this, your old CCG guidelines on dyspepsia management in primary care.

FOI 5097 – 1) Does SNEE ICB offer NHS Neuro support for adults with CP?
2) If so, what is the address/website?
3) What are the referral criteria? (where must they reside, their minimum age, any other info.)
4) Who can refer them to these services? (GP, hospital, social services, self-referral etc)
5) How to refer? (Is there an online form available?)
6) Who makes up the Neuro team? (Physiotherapists, Occupational Therapists, Speech and Language Therapists and so on.)

FOI 5098 – Request for copies of any email or WhatsApp correspondence to or from the medical director or equivalent of your health board or integrated care board – including any correspondence sent via their PAs or secretaries – since 1 April 2021, containing the following terms within the body of the email or any attachments:

Long Covid AND, any of the following:

Nice OR National Institute for Health and Care Excellence guidelines ; GMC OR General medical council; Medicalise; Psychological; Functional; Psychosomatic; Fabricated OR FII.

FOI 5099 – 1.What is the name of the Sexual Health Platform commissioned by the ICS / ICB?
for example INFORM Sexual Health provided by INFORM, Lilie proved by Idox and MAXIMS PreView solution provided by Maxims
2.The Name of the Provider of the Sexual Health Platform?
3.The date start date and end date of the current contract?
4.The name and email of the person within the ICB/ICS that is responsible for The Sexual Health Platform?

FOI 5100 – 1.Copy of the strategic needs assessment undertaken to help ensure local hearing needs are met.
2.The current waiting times for audiology services, including but not limited to diagnostic assessments, hearing aid fittings, and follow-up appointments, broken down by type of service if available.
3.The total number of individuals currently on the waiting list for adult audiology services, categorised by the type of service they are awaiting.
4. Any available data or statistics regarding trends in waiting times for audiology services over the past twelve months.
5.Details of any measures or initiatives implemented to address or reduce waiting times for audiology services, along with any associated outcomes or improvements observed.

FOi 5101 – 1. Is urgent mental health support available through NHS 111 in the region of your Integrated Care Board?
2. If no, are there plans in place to provide urgent mental health support through NHS 111? And when are these expected to be completed?

FOI 5102 – 1. Confirmation of the names and contact information (address or email) of all private sector providers currently commissioned to provide NHS funded cataract operations in your region.
2. Summary of how the ICB is monitoring/intending to monitor whether the independent sector providers they commission are meeting this specification.
3. Planned arrangements for providers found to be in breach of the contract specification to provide 11% of cataract operations as wholly delivered by NHS ophthalmic trainees within 2 years.
4. Number of NHS funded cataract procedures performed at each provider in England, divided into yearly information 2021, 2022, 2023.
5. Number of NHS cataract procedures performed at each provider in England, wholly performed by an NHS ophthalmic trainee, divided into yearly information for 2021, 2022, 2023.
6. Any formal comment from the ICB on the perception that independent sectors are not providing the agreed training and/or are detrimental to NHS trainees.

FOI 5103 – • What was the total amount of funding available to PCNs in your ICB area for the capacity and access improvement payment (CAIP)?
• How many PCNs in your ICB area submitted a plan for the capacity and access payments?
• How many PCNs in your ICB area received the national capacity and access support payment?
• How many PCNs in your ICB area received any money via the local capacity and access improvement payments (CAIP)?
• Can you please provide the amount of money received by each PCN as part of the local capacity and access improvement payments compared to the amount they were entitled to receive?
• And if this was less than 100%, can you please state why?
• These CAIP payments were split into three criteria – patient experience of contact, ease of access and demand management, and accuracy of recording in appointment books. Please provide for each PCN in your ICB the amount received per criteria.
• Who within your ICB assessed the delivery of the plans?
• Under what criteria was the delivery of the plan assessed?
• When were/will the payments be delivered to PCNs?
• How much CAIP funding was not allocated in your ICB area?
• What did the ICB do with the funding that wasn’t delivered in these payments?

FOI 5104 –

• What is the total ARRS allocation sum for the PCNs in your ICB?
• How many PCNs are in your ICB?
• How much ARRS underspend has the ICB recorded in its footprint?
• Does the ICB intend to reallocate this money to PCNs? If not, why not?
• How many bids did the ICB receive for this money?
• On average, how much money did each bid ask for?
• Can you share the bid documents with us in a way to account for the large file size?
• How many of these bids were successful? As a number and a percentage.
• How much money will be redistributed?
• When will this money be redistributed?
• If the money is not redistributed, what will it be used for?

FOI 5105 – List of all Tier 2, Tier 3 and Tier 4 weight management services providers in the ICB.

FOI 5106 – Which primary care rebate schemes ICB/ Health Board are currently signed up to? The start and end dates of the contracts.

FOI 5107 –

• When is the ICB going to implement NICE TA943 and if not what would be the reason for not doing so?
• What policy is currently in place within the ICB for use of Hybrid Closed Loop Systems?
• When does the ICB plan to have a policy in place in line with TA943

FOI 5108 –

•how much money your integrated care board (ICB) spent on hospice services for children and young people with life-limiting or life-threatening conditions in 2023/24
•how many children and young people with life-limiting or life-threatening conditions in your ICB footprint accessed hospice care during 2023/24
•how much money your integrated care board (ICB) plans to spend on hospice services for children and young people with life-limiting or life-threatening conditions during 2024/25, excluding the £25 million Children’s Hospice Grant funding that NHS England has asked every ICB to distribute.

FOI 5109 – For the twelve months from January 2023 to January 2024, please provide a breakdown of the following:
1. The number of pharmacies which permanently closed in your Integrated Care System.
2. The number of temporary pharmacy closure days recorded in this period, per pharmacy.
3. The duration of closures on each day, per pharmacy.
4. Reasons provided for closures at each pharmacy.

FOI 5110 – Information on all the formal accreditation processes that the ICB has undertaken. For each one provide information:
1. The date the process began
2. The date the process ended, if it has concluded
3. The name of the supplier seeking accreditation
4. The service they are seeking to supply
5. The outcome of the process.

FOi 5111 –
1.The number of outpatient ophthalmology (treatment function code 130) appointments for first attendance (WF01B) commissioned by the ICB from the following companies for the financial year 2022/23 and the amount paid by the ICB to these companies for delivering these outpatient appointments in 2022/23.
Spamedica
Newmedica
Optegra
Community Health Eye and Care Limited
Anglia Community Eye Services Limited.
2.The number of outpatient ophthalmology appointments for follow up attendance (WF01A) commissioned by the ICB from the following companies for the financial year 2022/23 and the amount paid by the ICB to the above mentioned companies for delivering these outpatient appointments in 2022/23.
3.Any documents containing the arrangements which have been put in place by the ICB or its predecessor bodies with the companies listed above for the sub-contracting of the delivery of outpatient appointments to other providers, for example but not exclusively optical businesses or high street optometry providers.
4.Any data held by the ICB relating to the delivery of NHS outpatient ophthalmology appointments by companies which have been sub-contracted to do so by the companies listed above – (for example the number of ophthalmology out patient appointments commissioned from any of the companies above which have been subcontracted to other companies to carry out on their behalf).

FOI 5112 –

1) A list of all the GP APMS contracts in your area
2) The names of the current providers who were awarded these contracts and when they were awarded the contracts
3) The names of the providers who held the contracts just before the current providers.

FOI 5113 – 1: The number of GP premises within the ICS
2: The cost of backlog maintenance for primary care premises within the ICS.

FOI 5114 – The name and email address of the People within your organisation that hold the following job titles / responsibilities
People and Organisational Development
• Director of Human Resources / Chief People Office
• Deputy Director Human Resources
• Director of Workforce
• Head of Leadership & Organisational Development
• People Systems & Workforce Information Manager
• Head of People Business Partnering
Finance
• Director of Finance
• Deputy Director of Finance
• Head of Procurement
Executive Board
• Medical Director
• Director of Information Technology
• Director of Innovation and Infrastructure
• Chief Operating Officer.

FOI 5115 –

1. What is the standard rate set at for carers in Personal Health Budgets (Direct Payments) when calculating a PHB?
2. What is the process for determining this rate for carers within a Personal Health Budget (Direct Payment)?
3. Which organisation decides / has authority on setting/finalising this rate (e.g. ICB, Local Authority, etc) for Personal Health Budgets (Direct Payments) that you are responsible for under NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD?

FOI 5116 –

1. What is your current budget for promoting / marketing Personal Health Budgets to the general population in England?
2. Where do you promote Personal Health Budgets to the general population (e.g. online, surgeries, hospitals, local groups, etc.)?
3. Do you have a strategy specifically for Personal Health Budgets in NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD?
4. Can you share this strategy (if yes to answer 3.)?
5. What resources do you offer/provide to people, parents, etc. on Personal Health Budgets?
6. Do you use 3rd parties for this promotion/resource activity or use in-house NHS resources?

FOI 5117 – Details for Cardinal Medical Practice.

FOI 5118 – When will the latest Procurement Strategy be ready to share.

FOI 5119 – What is the ICB’s most recent fertility policy.

FOI 5120 – Spending on absorbent continence products within the ICB in the last 5 years.

FOI 5121 – Cardinal Medical Practice – how may GPs are on the books and the breakdown as to full time, part time or locum.

FOI 5122 – Spend on Office supplies and associated products for the below financial years.
1st April 2022 – 31st March 2023
1st April 2023 – 31st March 2024
Start date & duration of Contract?
Is there an extension clause in the contract and, if so, the duration of the extension?
Has a decision been made yet on whether the contract is to be either extended or renewed?
Who is the senior officer (outside of procurement) responsible for the contract?
Name of Incumbent Supplier?
How long have you traded with them?
If you publish your register of contracts and purchasing, can you please provide a website link.
In addition, can you confirm if you have a contract in place for Tail End Spend.

FOI 5123 – Contract information with regards to the organisation’s telephone system maintenance contract (VOIP or PBX, other) for hardware and Software maintenance and support if all the information is still the same besides the contracts dates please send just the new contract dates. It would be much appreciated.
1. Contract Type: Maintenance, Managed, shared (If so, please state orgs)
2. Existing Supplier: If there is more than one supplier, please split each contract up individually.
3. Annual Average Spend: The annual average spends for this contract and please provide the average spend over the past 3 years for each provider
4. Hardware Brand: The primary hardware brand of the organisation’s telephone system.
5. Number of telephone users:
6. Contract Duration: please include any extension periods.
7. Contract Expiry Date: Please provide me with the day/month/year.
8. Contract Review Date: Please provide me with the day/month/year.
9. Application(s) running on PBX/VOIP systems: Applications that run on the actual PBX or VOIP system. E.g., Contact Centre, Communication Manager.
10. Telephone System Type: PBX, VOIP, Lync etc
11. Contract Description: Please provide me with a brief description of the overall service provided under this contract.
12. Go to Market: How where these services procured, please provide me with either the tender notice or the framework reference number. Please specify if procured through other routes.
13. Contact Detail: Of the person from within the organisation responsible for each contract full Contact details including full name, job title, direct contact number and direct email address.

FOI 5124 – Information about ICB compliance with NICE guidelines NG119, Cerebral Palsy in Adults https://www.nice.org.uk/guidance/ng119, specifically with regards to the orthopaedic services.

FOI 5125 – What payments, if any, you made to Stonewall (officially Stonewall Equality Limited) in the financial year 2022/23 and 2023/2 andd in the current year.

FOI 5126 –

1. Overview of Communication Services Funding and Providers:
o Detailed overview of the current communication services (including SMS, email, and patient engagement platforms) funded by the ICS for use in GP practices within ICB’s jurisdiction?
o All providers currently contracted to supply these communication services, specifying the nature of the services they provide in full.
2. Procurement and Contract Details:
o Detail the procurement process followed for selecting communication service providers, specifically mentioning any open tenders or frameworks used?
o For each contract awarded for communication services in the last five years, please provide:
 The name of the awarded provider,
 The value and duration of the contract,
 The specific services covered under the contract.
3. SMS/Text Messaging Specifics:
o Regarding contracts awarded, provide the rationale for the selection, particularly in terms of cost-effectiveness, service comprehensiveness, and any unique features or benefits that influenced the decision?
o Were any contracts directly awarded without a competitive tender process? If so, please provide the reasons for this approach and any documentation justifying the decision.
4. Future Procurement and Innovation Opportunities:
o Are there any upcoming opportunities for new providers to bid on communication services within the ICS?
o How does the ICS support innovation in patient communication and digital health solutions? Are there specific criteria or challenges you are looking to address with future procurements?
5. Compliance and Framework Agreements:
o Confirm whether the contracts with current communication service providers, adhere to NHS procurement guidelines and framework agreements.
o If there have been any deviations or exemptions in following standard procurement protocols, provide details and justifications for these cases?

FOI 5127 –

1.Does the Integrated Care System have a data strategy in place, either as a standalone strategy or as part of a broader digital or BI strategy? If yes, please provide a copy.
2.Is the same/similar data set used for the Shared Care Record?

FOI 5128 –

1. What is the name of the accountable lead for developing Women’s Health Hubs (WHHs) in your Integrated Care System (ICS)?
•This will be the primary contact for NHS England national and/or regional team to engage with when discussing progress against key WHH milestones.
•The accountable lead is the person responsible for the overall delivery of the WHH in your ICS.
•This may be the Women’s Health champion or another senior leader
2. What is the email address of the accountable lead?
3. How many WHHs are being developed or expanded in your ICS using DHSC’s £25 million transformation fund?
4. Are you on track to have at least one operational WHH in your ICS providing at least 2 core services (as outlined in the WHH core specification) by end of July 2024?

FOI 5131 – Adults Continuing Healthcare lead : Name / Tel and email address & Children’s Continuing Healthcare lead : Name / Tel and email address.

FOI 5053 – Is SNEE ICB commissioning any rTMS (Repetitive Transcranial Magnetic Stimulation) services?  Answer: No

FOI 5054 – 1. Do you currently have a contractual agreement in place for supply of services from S12 Solutions Limited based at 5 Kelso Place, Bath BA1 3AU?
2. If yes, when is that agreement due to end?
3. Could you please provide a copy of the service/product specification given to all bidders for when this contract was last advertised?
4. Is there an extension clause in the contract and, if so, the duration of the extension?
5. Has a decision been made yet on whether the contract are being either extended or renewed?
6. Who is the senior officer (outside of procurement) responsible for this contract?
7. What is the total value of the contract?

FOI 5055 – The Suffolk and North East Essex Integrated Care Board (SNEE ICB) submitted a bid for a share of this £30 million funding to roll out innovative technology.  What is the value (a share of the £30m) submitted/allocated to the SNEE ICB?

FOI 5056 – 1. Job title of the MSK lead for the ICS
2. Name of the MSK lead for the ICS
3. Does this role cover children’s services or only adults?
4. Is this person funded for their work in this role?
5. Name and job title of lead for health equalities for the ICS.
6. What are the priorities for MSK service development for the ICS?

FOI 5057 – Please provide a list of the ‘Places’ within the ICB.
What is the name of the Director at each ‘Place’
Please provide the name/s of your Directors of Commissioning (or equivalent)
Please provide the name of your Director of Urgent or Emergency Care (or equivalent)

FOI 5058 – 1. Does your ICB provide Age-related Hearing Services (including hearing aid provision) throughout your ICB area? (Y/N). If there are areas or localities without provision, then please provide the reason(s) for this. Are there areas where distances for patients to travel to an appointment are deemed by the ICB, or relevant regulatory body to be excessive, or somewhat concerning? Please highlight any such areas, with an idea of the distances patients need to travel. This is likely to relate to smaller population, remote communities.
2. Is the Hearing aid provision set up differently across different areas within the ICB borders ? (Perhaps these sub-areas were inherited from the CCG era but still operating within the current ICB set up?) Please document the type of service set-ups within your ICB indicating the type for each area e.g. AQP, single provider, Community Services, ENT-led, Hopsital-based only etc.
3. Please let us know who the audiology providers are within the ICB .
5. When did the contract(s) start?
6. When is/was the contract end date according to the original contract ? (please detail for all contracts in the ICB area)
7. Has the contract been extended with existing Providers beyond the original contracted end date (without going to Tender)? (please detail all dates for all contracts in the ICB area. If they have been extended multiple times, then please itemise all extensions)
8. If the required contract renewal has been delayed beyond the original contracted End Date, then why was a new tender not issued and what are the intentions for the future required contracting of the service? please detail for all contracts in the ICB area, and send any documents or minutes of meetings that relate to the ICBs consideration of their options for the required future contract arrangements.
9. Are there plans to merge/harmonise multiple services within the ICB into one service Contract for the entire ICB? If so, then please supply information together with proposed start dates. Or are there any plans to change the Contract type significantly in some other way e.g. combine all into AQP, add ear wax removal to the service, change to self-referral model. Please highlight the reasons for the delay in harmonising the service or delays in changing contract specification. Please supply all internal/external documents and minutes of meetings that relate to this question.
10. Can a Provider be admitted to the contract mid-term/mid-contract? i.e. can new providers be admitted during the current contract, after the initial contract had been awarded. If so, please advise how the Provider would apply to be included within the Contracts Provider List for a mid-term entry. Please also advise how a new Provider could apply to be included at the point of Contract extending i.e. be added to the existing Providers when the original contract is extended. . If an interested Provider who holds similar AQP contracts currently elsewhere cannot apply to be added to the current Provider List mid-term during the a current contract, and cannot be considered at the point of the extension of an existing current contract, then please indicate on what grounds the ICB feels this entry would not be acceptable.
11. What are the current typical wait times for accessing (the various) Hearing Aid Services within the ICB? Please also indicate the areas or localities within the ICB where wait times have breached KPIs in more than two months within the last 6 months.
12. Have any Providers left the contract for any reason, or restricted their intake very significantly ? Please provide as much detail as possible.
13. Have any current Providers been awarded the current Contract without the ICB tendering the opportunity? And why was this deemed permissible? This may be a short term contract that was issued for emergency reasons e.g. due to COVID or Provider terminating their service suddenly. Please detail contract extensions and indicate on what grounds the ICB felt they were able to directly award the contract, and on what grounds they felt that they were not obliged to issue a tender to the market or invite new Providers to apply.
14. Have there been any material changes during the course of the current specification. (This includes changes during the period of any contract extensions that were based on the Original contract)
15.a. For AQP services within the ICB, are there any areas or localities where services are currently only available from a single Provider?
b. For AQP services within the ICB, are there any areas or localities where services are currently only available from a single Provider for in-clinic appointments, as per activity reports in the last 3 months?
c. For AQP services within the ICB, are there any areas or localities where domiciliary services are only active from a single domiciliary Provider, as evidenced in ICB activity reports in the last 3 months?
16. Please comment further on any future intentions for the procurement of Age-related Hearing services within the ICB (that may not have been mentioned above). Please send any available documents or meeting minutes that support your answers to this issue.
17. Will commissioners be reviewing the current contract under the new Provider Selection Regime (PSR)? Please detail how the ICB will issue contracts under the PSR requirement. What is the ICBs understanding of how AQP Audiology fits within the PSR requirement, and how does the ICB understand how PSR requirements should be executed for AQP Audiology?
18. What are the referral to assessment times for patients being seen for domiciliary services specifically? Has this been breached by any Provider for two or more of the last 6 months? Are there any areas or localities where domiciliary services are not available in the ICB?
19. In reviewing the KPI data for domiciliary services, would the addition of a new domiciliary Provider improve the service for patients?
20. Please could you inform us of any tariff uplifts, if so, how much and which year(s)?
21. Are there any areas or localities within the ICB where there are typically days without provision e.g. Sundays or Bank Holidays? Similarly, are there any areas or localities where evening appointments are not provided i.e. between 6pm and 8pm?
22. NHS hearing aids are now available with Bluetooth functionality, providing better value to NHS, taxpayers and patients when fitted. Are any Providers in your area providing less than 75% of their hearing aids without Bluetooth enabled features including mobile phone streaming, remote control Apps, remote aftercare? Please itemise for each Provider. Please state whether the Provider’s ‘standard’ model(s) provision tends to include or exclude these Bluetooth-enabled functions for their cohirt.
23. Has the ICB noted any areas of concern re Health Inequalities or Access within the current Provision of services? Are there KPIs or Standards not being met with regard to Health Inequalities and /or Access?
24. NHS England has made self-referral a requirement of AQP audiology. Has Self-referral been implemented for the ICB’s Audiology contract(s)? Please provide the self-referrral commencement dates. If Self-referral has not been implemented, then on what date will Self-referral commence?
25. Is ear wax removal part of the audiology pathways? If so when was this implemented? If not, then please detail any documented plans to integrate ear wax removal as part of the Audiology pathway.
26. Separate Ear Wax Removal Pathway – Do you have an Ear Wax Removal pathway (that is entirely seperate from the Audiology service a)?
If yes the please provide the following information
a. When did the contract start?
b. When is the contract end date?
c. Who is the Contracted Provider (or Providers)
d. Was the contract subject to a market Tender? If so please send us the link to the Tender.
e. If there was no open market Tender then how were the Providers or the Provider selected ? On what grounds, with what rationale and with what selection process were the Providers or the Provider recruited ?
f. If the current Contract was extended then on what grounds was the contract extended ? Using what rationale ? Why was the contract extended and a competitive Tender not applied ?
g. Can new Providers be considered for entry mid-term, at contract extension , or via Tender process. Please advise the process required for a new Provider to apply.
h. Will PSR be applied to future ear wax contracts? How will the PSR process be implemented given the different ways that PSR should be used to issue awards?

FOI 5059 – 1. The estimated total number of acres of land that ICB owns.
2. The estimated total number of acres that ICB owns which are not in operational use.
3. The annual spending on managing and maintaining your property estate in the financial year 2022/23. Please provide a breakdown.
4. The number of empty homes ICB currently owns.
5. The number of empty buildings ICB currently owns that are not homes.

FOI 5060 – NHS Continuing Healthcare (CHC) packages for adults aged 18+ within ICB.

FOI 5061 – Total number of Children’s Continuing Care cases at the time of this request (Feb/Mar 2023) or most recent figures (Q3 2023/24). Please could you state with response the date the figures relate to.
Total number of Children’s Continuing Care cases in the last financial year (2022/23)
Total spend for Childrens Continuing Care cases in the last financial year (2022/23).

FOI 5062 – 1. For Q3 2023/24 – Total number of Adults (from 18-25) who have Personal Health Budget with an EHCP in place?
2. From the above (1) cases, how many have an Integrated Budget?
3. From the above (2) cases, how many are classified as Direct Payments / 3rd party / Notional.
4. From the above (2), what is the split (%) for Lead Commissioner (i.e. ICB, Local, Authority, etc.).

FOI 5063 – 1.Do you have a local formulary which you follow alongside the NHS England commissioning recommendations?
2.If so, when will the local formulary be reviewed?
3.The name (s), direct contact email address (es) and direct telephone numbers of the person (s) who are dealing with the formulary
4.A link for the local formulary.

FOI 5064 – 1. Does the ICS / former CCGs offer a locally enhanced service incentive scheme (e.g. for the management of long term conditions, targeting of specific patient cohorts or admission avoidance) to your GP practices, or has a scheme of this nature been offered in the last 5 years?
2. If so, please can you provide the scheme documentation shared with GP practices, or details of all the components of the scheme, such as:
a. The specific measure (e.g. Diabetes 8 Care Processes)
b. The patient cohort (e.g. patients currently diagnosed with Diabetes)
c. The payment mechanism (e.g. payment per patient, achievement of a lower or upper threshold, or target)
d. The funding allocated to the measure (e.g. £1 per head of population, £1 per 1000 Diabetic patients)
3. If locally enhanced service incentive schemes are not provided, does the ICS / former CCGs have a scheme that supported GP practices with additional funding, or has a scheme of this nature been offered in the last 5 years?
4. If so, please can you provide the details of this scheme?

FOI 5065 – Mean average wait between booking a GP appointment and the GP appointment taking place in days at your organisation in each of the calendar years a) 2019, b) 2020, c) 2021, d) 2022, e) 2023
Number of patients who waited more than 42 days between booking a GP appointment and the GP appointment taking place at your organisation in each of the calendar years a) 2019, b) 2020, c) 2021, d) 2022, e) 2023
Number of patients who waited more than 56 days between booking a GP appointment and the GP appointment taking place at your organisation in each of the calendar years a) 2019, b) 2020, c) 2021, d) 2022, e) 2023
Number of patients who waited more than 182 days between booking a GP appointment and the GP appointment taking place at your organisation in each of the calendar years a) 2019, b) 2020, c) 2021, d) 2022, e) 2023
Number of patients who waited more than 365 days between booking a GP appointment and the GP appointment taking place at your organisation in each of the calendar years a) 2019, b) 2020, c) 2021, d) 2022, e) 2023
The longest time a patient waited between booking a GP appointment and the GP appointment taking place in days at your organisation with the appointment taking place in the calendar year of 2023

FOI 5066 – List of Memory Clinics or other localities where patients are seen for diagnosis and/or treatment for dementia within the ICB locality
Job Titles and if possible, names of the key health care professionals at the memory clinics
Contact Address and telephone number of the memory clinics
Mailing Address if different from above.

FOI 5067 – For the below 3 services which are part of the clinical specialty cardiology:
Adults Community Cardiology Services
1.Please provide a list of all providers the ICB holds contracts with for this service.
2.For each contracted provider, please provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification)
Adults Community Heart Failure Service
3.Please provide a list of all providers the ICB holds contracts with for this service.
4.For each contracted provider, please provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification)
Adults Cardiac Rehabilitation Service
5.Please provide a list of all providers the ICB holds contracts with for this service.
6.For each contracted provider, please provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification).

FOI 5068 – 1.The median length of time from referral to autism services to receiving an autism assessment in Suffolk and North East Essex for children.
2.The median length of time from referral to autism services to receiving an autism assessment in Suffolk and North East Essex for adults.
3.The median length of time from referral to autism services to receiving the final outcome of an autism assessment (i.e. a positive or negative diagnosis) in Suffolk and North East Essex for children.
4.The median length of time from referral to autism services to receiving the final outcome of an autism assessment (i.e. a positive or negative diagnosis) in Suffolk and North East Essex for adults.
5.The conversion rate of autism assessments to autism diagnoses in Suffolk and North East Essex for children.
6.The conversion rate of autism assessments to autism diagnoses in Suffolk and North East Essex for adults.
7.What support and further referral is routinely offered to children who receive an autism diagnosis through Suffolk and North East Essex ICS.
8.What support and further referral is routinely offered to adults in who receive an autism diagnosis through Suffolk and North East Essex ICS.
9.What support and further referral is routinely offered to children who undergo an assessment for autism through Suffolk and North East Essex ICS but do not receive a diagnosis.
10.What support and further referral is routinely offered to adults who undergo an assessment for autism through Suffolk and North East Essex ICS but do not receive a diagnosis.
11.What standardised tools are currently used in Suffolk and North East Essex for the screening and/or triage of children who seek an autism assessment.
12.What standardised tools are currently used in Suffolk and North East Essex for the screening and/or triage of adults who seek an autism assessment.

FOI 5069 – The membership of ICP
The names and/or positions and organisations of the Community / VCSE representative currently serving in the Integrated Care Partnership.
Any criteria or selection process documentation that outlines how these VCSE representatives were chosen to be part of the ICP.
Minutes or summaries of any meetings or discussions that led to the decision of including these two VCSE representatives in the ICP, if available and not exempt from disclosure.
Information regarding the number and names of trusts that are part of the ICS.

FOI 5070 – ICB to provide their 2024 / 2025 list of capital schemes as detailed within the Joint Capital Resource Use Plan 2024/ 2025, covering the following items:
• Region
• ICB / System
• Introduction
• Assumed Sources of Funding for 2024 / 2025
• Overview of Ongoing Scheme Progression
• Risks and Contingencies
• Business Cases in 2024 / 2025
• Cross System Working
• Capital Planning & Prioritisation
• Capital Plan

FOI 5071 – Full dataset for ICS system in the primary care data gathering programme.

FOI 5072 – What core and supplementary hours are recorded with the authorities for each location. Details of the following:
Colchester – FWC51
Ipswich – FNJ81

FOI 5073 – Wait times for the following assisted conception procedures (in weeks) from referral to procedure from June 2023 to the present, or the latest available 6 months of data:

Intrauterine insemination (IUI)
In vitro fertilisation (IVF)
Egg and sperm donation
Total number of referrals for assisted conception procedures carried out, by location
Total number of referrals submitted, by location.

FOI 5074 – 1. Has ICB commissioned services for diagnosis and management of people with FASD (Fetal Alcohol Spectrum Disorder)
a) For children
b) For young people
c) For adults
2. If yes, who has been commissioned to do this and what the pathway is, and provide any relevant documents.

FOI 5075 – 1. What percentage (%) does NHS SUFFOLK AND NORTH EAST ESSEX INTEGRATED CARE BOARD use the following methods to promote / support these 41 CCC Direct Payment PHBs?
a. 3rd Party support companies (e.g. Enham Trust, Penderels, Solo Support, etc).
b. ICB direct engagement/communication
c. No support in place
d. Do not hold this information.
2. How often are Direct Payments PHB options promoted / advertised to the PHB community within your ICB?
a. On initial PHB discussion at beginning of PHB journey
b. Continuously / regularly through PHB lifespan
c. On request
d. Never
e. Do not hold this information.
3. Of these 41 CCC Direct Payment PHBs, what percentage (%) have employers / carers insurance?
a. 75-100%
b. 50-75%
c. 25-50%
d. 0-25%
e. Do not hold this information.
4. Of these 41 CCC Direct Payment PHBs, what percentage (%) have contracts of employment for their employed carers?
a. 75-100%
b. 50-75%
c. 25-50
d. 0-25%
e. Do not hold this information.
5. Of these 41 CCC Direct Payment PHBs, what percentage (%) require regular medical training for their employed carers?
f. 75-100%
g. 50-75%
h. 25-50%
i. 0-25%
j. Do not hold this information.
6. Of these 41 CCC Direct Payment PHBs, what is the percentage split (%) of clinical oversight (main lead) for the PHB?
k. Childrens Community Nurse (CCN)
l. Registered Nurse (funded by the PHB package)
m. Registered Nurse (not funded by the PHB package)
n. ICB Clinical Lead
o. Do not hold this information.

FOI 5076 – Community pharmacy independent prescribing pathfinder programme
1. How many Pathfinder sites did you have within your area as at 31 January 2024?
2. How many Pathfinder sites do you have within your area now?
3. How many expressions of interest/applications were received to take part in the Pathfinder pilot in your area?
4. What criteria were used to score expressions of interest/applications?
5. How many of those who expressed an interest/applicants were accepted from the total that applied?
6. Please provide details of much will those (i.e. a contractor) receive for taking part in the Pathfinder programme including any set up payment, monthly payments etc.

FOI 5077 – Full organisational structure charts (band 8a and above) for all departments to include names, job titles and contact details.

FOI 5078 – Guidelines for the treatment of the following conditions.
o Psoriatic Arthritis (PsA)
o Axial Spondyloarthritis (AxSpA)
o Ankylosing Spondylitis (AS)

FOI 5079 – Concerning Social Prescribing Link Workers (SPLWs), or other workers who undertake the role of a SPLW with different role titles:

1. How many SPLWs are employed by Primary Care Networks (PCNs) in your Integrated Care System (ICS)? Please give the number of heads and WTE if possible.
2. Does each PCN in your ICS employ a SPLW?
3. Do any PCNs share a SPLW (or employ the same SPLW as another PCN)?
4. Are there any SPLWs in your ICS who are employed by organisations other than PCNs?
If so, do you know how many and who employs them?
5. Please tell me how many patients/clients were referred to (a) PCN-employed SPLWs and (b) other SPLWs based in your ICS during the financial year 2022-23 or calendar year 23, whichever is easier.
6. Which body is responsible for monitoring the activities of SPLWs (e.g., ICB, PCN)?

FOI 5080 – 1. How many people were referred to addenbrookes for tier 3 weight management from March 2023 to March 2024? Please also break it down to how many per month
2. How many people were referred to Luton for tier 3 weight management from March 2023 to March 2024? Please also break it down to how many per month
3. How much does each tier 3 weight management referral to cost the ICB?
4. Does the ICB plan to have their own tier 3 management service in the future? If what information do you have regarding this?
5. How many requests for tier 3 weight management have been rejected from March 2023 to March 2024? Please also break it down to reasons why.

FOI 5081 – Information about treatment of Duchenne muscular dystrophy (DMD) by ICB:
•Does your organisation commission any services for people with DMD?
oIf no, does your organisation expect to commission services for DMD in the future?
oIf yes, what services for people with DMD does your organisation commission?
•How many people with DMD does your organisation serve?
•Does your organisation have any DMD-specific (or muscle-wasting disease-specific) policies or guidance?
•Do any of your organisation’s strategies, objectives, plans, performance indicators, audits, inspections, or similar, cite DMD (or any muscle-wasting disease) or use either as a metric?
•Is your organisation aware of the work of DMD Care UK.

FOI 5082 – Total ARRS budget
Expected total ARRS underspend
Plans for any unclaimed funding, specifically:
a) Is the ICB inviting PCNs to bid for unclaimed funding?
b) If yes to a), how much of this funding has been reallocated?
c) If yes to a), how many PCN bids have been approved for unclaimed funding?
d) If no to a), what are the plans for unclaimed funding, if any?

FOI 5083 – A copy of any assessment undertaken by the ICB – contained in the form of internal reports or presentations – of the impact on waiting times for patients seeking ophthalmology services as result of the use of the independent sector to deliver cataract surgery.
A copy of any audit or assessment undertaken by the ICB– contained in the form of internal reports or presentations – of the electronic/digital/online system for the referral of patients from optometry practices to NHS Trusts or independent sector providers.
A copy of any letters or correspondence between the ICB and representatives of local optometry businesses – for example Local Optical Committees – regarding the referral of NHS funded patients to independent sector providers and NHS Trusts.

FOI 5084 – Ophthalmology treatment code 130 questions for the years 2022-2023 and 2024 (if available). Include all activity against codes WF01A, WF01B, WF02A, WF02B

1. the total number of patients referred for ophthalmology treatment in the last 12 months
Inpatients
Outpatients
2. For inpatient treatment, total admissions per month, average length of stay, number of admissions by day of week per month and discharges by day of week per month
3. Total referrals from Primary Care and originating ICS by month
4. Total wait for first appointment, total new, follow up (as above) and then total wait to first appointment and total wait for follow up appointment, number of patients currently waiting for first appointment and number waiting for follow up appointment
5. Number of patients who had first appointment cancelled and re-referred to another provider
6. Number of patients in point 5 who were referred to another NHS provider
7. Number of patients in point 5. who were referred to Private Provider.

FOI 5085 – Any employer/GP practice ‘scope of practice for nursing associates policy’ or similar title. This is a document that outlines what tasks nursing associates are permitted to carry out and in what circumstances.
Some employers do not hold these types of policy. If you do not, we would like to see example job descriptions for nursing associates.

FOI 5086 – 1. how may GPs are on the books of each of the 5 Surgeries in the Ipswich Northern Fringe area and the breakdown as to Full Time, Part Time or Locum.
2. How may ‘Full Time equivalents’ does this amount to, in effect, at each surgery.
3. The report indicates that currently most surgeries are operating ‘outside/beyond’ the recommended patient levels numbers. Is this still the case as we are unsure of the date that report dada was collected?

FOI 5087 – 1) The amount spent by the ICB on the following companies for the period 1 January 2021 to 31st December 2022 and the number of cataract operations purchased from these same companies during this period.
– Spamedica Ltd
– Optegra UK Ltd
– Anglia Eye Care Service Ltd
2) The amount spent by the ICB on the following company for the period 1 July 2021 to 30 June 2022 and the number of cataract operations purchased from this company during this period.
– Community Health and Eye Care Ltd (CHEC)
3) The amount spent by the ICB on the following company (or any of its subsidiaries) for the period 1 March 2022 to 28 February 2023 and the number of cataract operations purchased from this company or any of its subsidiaries during this period.
– Newmedica Systems Ltd (Newmedica).

FOI 5088 – Does your ICB currently offer patients the weight loss medication Wegovy for adults in line with NICE TA875?
Has there been any prescriptions of Wegovy to date from Tier 3 weight management services within your ICB since the release of NICE TA875?
Has the ICB previously offered weight loss medication Saxenda for adults in line with NICE TA664 prior to national supply issues?
Has there previously been any prescriptions of Saxenda to date from Tier 3 weight management services within your ICB since the release of NICE TA664?
If the medicines are provided within the ICB, are they available to prescribe within all Tier 3 services in the ICB?
If the medicines are provided within the ICB, are there any changes to prescribing criteria compared with NICE TA664 and NICE TA875?

FOI 5089 – The criteria for keloid scar excision and more information about the appropriate/recommended channels of seeking approval via IFR (Individual Funding Requests).

FOI 5090 – MSK service in SNEE ICB Region.
How is the service delivered in your region? Ie: do you have a prime contract holder? Is it a collaborative provider? Do you have multiple provider contracts?
Sub-contracted via Acute Providers
What model do you plan to use moving forwards (ie: prime provider, collaborative…)?
Who is the prime contract holder for your region?
Who are the other MSK contract holders in your region?
What is the financial envelope for each MSK contract in your region? Please specify the time period this covers.
Is community MSK split out from the rest of MSK services?
What are ICB’s MSK goals for RTT, GURFT and FFT?
How are MSK providers performing against RTT, GURFT and FTT?
What are MKS goals for reported patient outcome measures?
How are MSK providers performing against reported patient outcome measures?
What is the length of current MSK contract(s) and when is it(they) up for renewal?
What are priorities for MSK in the next 3 years?

FOI 5093 – Copy of the current  contract with Forest Surgery, Brandon.

FOI 5094 – Type of formal procedure which is in place to enable patients to transfer their registration to a neighbouring area.

FOI 5004 – How many tier 4 referrals did Colchester set CAMHS make within the last 12 months.

FOI 5005 – The number of patients who have been charged solely for BAND 1,2,3 Course of Treatment and what was the total amount inclusive of whether the patient has fully paid themselves, partly paid or has been fully funded for these costs under NHS provision.

FOI 5006 – 1. The name and email address for the Manager responsible for the Local Maternity and Neonatal System?
2. The name and email address for the Project Lead for the Local Maternity and Neonatal System?
3. The name and email address for the Director responsible for Local Maternity and Neonatal System Lead?
4. The name and email address for the Manager for Maternity Service?

FOI 5007 – A list of the services that your organisation decommissioned or plans to decommission in 2022-23, 2023-24, 2024-25 (planned).

FOI 5008 – Does ICB has a Trust-wide obesity and weight management strategy? If so, how is this implemented (for example, through delivery of Tier 3 obesity services of the NHS Tiered Care Weight Management Pathway)?
A. what are the details of staff training to deliver these strategies,
B. what are the details of any current training for clinical staff in the area of weight discrimination, weight stigma, weight bias and/or obesity awareness,
C. What is he number of complaints made to the Trust where weight discrimination, bias or stigma was mentioned in the period 1st January 2014 to 31st December 2023,
D. Are there any planned or current actions in response to the Health and Social Care Committee report on ‘The Impact of Body Image of Mental and Physical Health’.

FOI 5009 – Insights into the regional demand for domiciliary care services in the Suffolk area, as well as any information regarding the local government’s support for such initiatives.

FOI 5010 – What are the referral pathways between primary and secondary care, specifically for diabetic patients who are at moderate to high risk of developing lower limb diabetic complications.

FOI 5011 – 1. The total amount of money your ICB spent commissioning services for NHS patients from private health providers, broken down by month, since July 2022.
2. The total amount of money your ICB spent commissioning services for NHS patients from private health providers, broken down by private provider, since July 2022.

FOI 5012 – Does the ICB keep a record of Provider organisations with which it holds contracts.

FOI 5013 – Which organisation(s) provide your Talking Therapies Service and the contract expiry date.

FOI 5014 – List of low secure units which accept patients currently detained under the Mental Health Act 1983 who have a diagnosis of a Personality Disorder and a clinical likely diagnosis of Autism Spectrum Disorder.

FOI 5015 – 1.Who provides your non-emergency patient transport services (NEPTS)?
2.When does this contract run until?
3.What is the value of this contract per annum (i.e. for 2023/24)?
4.Do you contract your NEPTS for your organisation in isolation, or is it contracted jointly with other NHS organisations? If so, which other NHS organisations?
5.Who is the best person to contact regarding the NEPTS service for your organisation? Please provide name, position and contact details where possible.

FOI 5016 – 1. Are the Patient Care Transport Services provided by in-house or outsourced providers
2. What is the annual spend of the ICB region on Patient Care Transport Services
3. Who are current outsourced providers are and what are the duration of their current contracts
4. What is the ICB’s forward-looking budget for Patient Care Transport Services.

FOI 5017 – 1.What locally commissioned services are currently commissioned by the ICB, outside of the Community Pharmacy Contractual Framework.
2.The number of pharmacies commissioned to provide each service.
3.The value of each contract
4.The date of each contract.

FOI 5018 – What is the total cost of these PHB packages i.e. total cost of CCHC includes the total cost for each area – Direct Payments, 3rd Party and Notional Budgets so that a calculation can be made of the average PHB package cost for each area (e.g. Direct Payments Total Cost / Direct Payments Total No.).

FOI 5019 –  1.What is the current policy the ICB has on working from home for non-patient-facing staff.
2.What rules/ expectations/ policies are set by the ICB in terms of employees working from the office?
3.Are any staff groups exempt from these rules? If so, please give details
4.When was this policy issued?
5.Please could you detail any changes to the WFH policy from a) April 2020 and b) September 2022
6.Do you plan to change your work from home/ office policies in the next year? If so, please detail the changes
7.How regularly is the ICB monitoring office attendance/working from home?
8.How many staff in non-patient-facing roles are currently
•Working full time from the office
•Working full time from home
•Working from office 1 day a week
•Working from office 2 days a week
•Working from office 3 days a week
•Working from office 4 days a week
•Working from office 5 days a week
9.Has there been any disciplinary action taken against any member of staff for not working in the office? Are any cases being investigated?

FOI 5020 – Is ICB or intends to mandate that PCNs/GP practices switch patients already taking a direct-acting oral anticoagulant for atrial fibrillation to apixaban over edoxaban.

FOI 5021 – Number of junior doctors in your trust who are recorded as taking sick leave from the dates December 25th, 2023 – January 9th, 2024 inclusive.

FOI 5022 – List of community diagnostic centers within the system alongside the following information:
•Name of CDC
•Location of CDC
•Services that CDC provides
•Which trusts are aligned to the CDC
•The Senior Responsible Officer for Workforce and OR overall responsible officer
•Contact for SRO

FOI 5023 – Will the ICB directly commission the 59 services that are being delegated to it from April 2024 or are they going to be commissioned as part of a collaborative.
If it will be as part of a collaborative, what will be the identity of the other members of the collaborative and its name.
What is the name of the accountable officer for commissioning each of the services, and the names of those sitting on any commissioning committee or equivalent body.

FOI 5024 – End dates and details for all current NHS 111 call handling contracts within your geography? (including contracts that sit across ICS boundaries), is there an option to extend the contract, has it been triggered and if so when does it end? Who is the current provider? What is the estimated procurement announcements dates for renewal of the contracts above?

FOI 5025 – •What is the main provider of adult community health services in each of the areas served by the ICB?
•What is the main provider of children’s community health services in each of the areas served by the ICB?
•For each of the ICB’s main adult community health service provider contracts, which month and year is it due to run out?
•For each of the ICB’s main children’s community health service provider contracts, which month and year is it due to run out?
•For each of the areas served by the ICB, do you have any current plans to procure or award a new contract for its adult or children’s community health services?

FOI 5026 – The total number of patients currently on the waiting list to receive speech and language therapy services.

FOI 5027 – What is the availability of NT-proBNP testing.

FOI 5028 – Information about mental health support teams (MHSTs) that operate in the ICB area or that will be operational by the end of 2024.

FOI 5029 – The total amount of your ICS budget in pounds-sterling (£) that is allocated for funding dentistry in each of the financial years a) 2023-2024, b) 2023-2022, c) 2022-2021, d) 2021-2020, e) 2020-2019.

FOI 5030 – Primary care funding in the ICS.

FOI 5031 – 1.Have the funds been allocated to 1 or more ICB stakeholder and who would they be? 2.Who is the ICB Executive Lead for Women’s Health/Women’s Health Champion?

FOI 5032 – 1. How many hospitals are affected by RAAC concrete in your health board? 2. How many wards and patients are affected by RAAC concrete?
3. How much money do you spend monthly to make sure that hospitals and hospitals wards to ensure they are safe to use? 4. How do you ensure patients safety when In a ward that contains RAAC concrete?

FOI 5033 – How many nephrostomy procedures are conducted each year within your ICB?

FOI 5034 – The number of Very Senior Managers (VSM’s) the ICB employs, i.e., those above Agenda for Change Band 9 for the current year. The job title of those VSM’s. The salary bands of those VSM’s for the current full year.
The number of employees at Band 9. The job titles of those at Band 9.

FOI 5035 – For each provider, please provide a copy of Schedule 2A and Schedule 2Aii from the contract:
BMI Healthcare Ltd
InHealth
Spire

FOI 5036 – ‘North East Essex Adult Community Continence Formulary 2023/24’ – copy of all document(s) covering the previous period(s) up until the 21st February 2023 for the 10 year period from 2013 with information on the use of Urological Catheters.

FOI 5037 – 1. What Electronic Patients Records System(s) do you use and when was it implemented?
2. Does the ICB scan paper records? If yes, do you
– scan day forward and legacy records? or
– just day forward records?
3.Is above handled
– In house by your own scanning team?
– Outsourced to an off site external service provider?
– On site by an external provider?
– Combination of above?
4.If any of the above outsourced, please name provider(s) and details of when the contract(s) ends
5.What route to market used to obtain these services (a) open tender (b) framework – if yes, which one?
6.Do you have a published road map for paper-free at point of care ‘Digital at point of care’? If yes, please provide a copy or link to this document
7.Finally, please advise names of any individuals involved in this process including your Medical Records Manager (b) Chief Information Officer (c) Digital Project Lead?

FOI 5038 – Number of complaints made to the ICB concerning the practice of a physician associate (PA) working in general practice for each month since the establishment of ICBs in July 2022. (i.e. monthly data from July 2022 up to and including January 2024).

FOi 5039 – How much does ICB spent with First Options Healthcare from 1st January to 31st December 2023 on the provision of complex care packages within peoples own homes.

FOI 5040 – The total number of vaccinations administered for each of the following diseases, broken down by year.
Diseases/ illnesses:
Leprosy
Tuberculosis
Measles
Polio
Pertussis (Whooping Cough)
Smallpox
Typhoid
Cholera
Malaria
Typhus

FOI 5041 – What specialist NHS referral services are provided for people suffering from sleep disorders (such as sleep apnoea, narcolepsy, insomnia)?

FOI 5042 – Who is the Acute Provider Collaboratives Senior Responsible Officers (SROs)

FOI 5043 – Names of the trusts or organisations within your area/jurisdiction that provide wheelchair and Postural Seating services.

FOI 5044 – What is the total spending by ICB on unconscious bias training for your staff in the financial year 2022/23 and the number of staff that undertook unconscious bias training in the financial year 2022/23.

FOi 5045 – 1.Name and email address of the medicines management team member who led on the Eye Care (Chapter 11) formulary review when it was last reviewed?
2.Name and email address of the member of the ICS Medicines management team who is currently responsible for overseeing Eye Care formularies?
3.Do you have an area prescribing committee/Medicines Optimisation Committees/ Medicines advisory group or similarly named group that manages your drug formulary decisions?
4.Names and email addresses of all members of these formulary groups?
5.Copies of the previous two minutes from the Area Prescribing Committee/ Medicines Optimisation Committees/ Medicines advisory group or similarly named groups meetings.
6.Which products within Chapter 11 (Eye) of your formulary, you have a primary care rebate in place, when the agreement commenced, the rebate amount and the end date?
7.Does the ICS have a deficit forecast for 2023/2024 financial year? If so, how much is this deficit? And How much is the forecast deficit for 2024/2025 financial year?
8.What is the value of your ICS’s planned savings from the Medicines management drug prescribing budget in the financial year: 2023-2024? And 2024 – 2025?

FOI 5046 – List of Primary Networks within your area to include the following information for each PCN:
Name of PCN
Names of GP Surgeries within each PCN
Name of the Clinical Director for each PCN
The email address for the Clinical Director

FOI 5047 – Number of patients calling NHS 111 for the following conditions for the last 5 years
• Back Pain
• Chronic obstructive pulmonary disease (COPD)
• Falls (due to frailty or age)

FOI 5048 – 1) The total annual number of referrals to fertility units within your ICS in years 2020, 2021, 2022 and 2023
2) How many of these referrals, per year, were rejected?
3) What was the average waiting list time for referrals, per year, to fertility units within your ICS?
4) How many of these referrals, per year, were rejected due to missing/incomplete tests?

FOI 5049 – Number of abortions broken down by ethnic group, then from ethnic groups broken by the age of the women, broken down by how many weeks pregnant and the gender of the baby (if known).

FOI 5050 – The total amount of money ICB spent commissioning services for NHS patients from private health providers, broken down by month and by private provider, since July 2022.

FOI 5051 – working with GenderGP.

FOI 5052 – For the 2022 / 23 financial year (between 1st April 2022 and 31st March 2023), what was (a) the total value (£) of East Suffolk and North East Essex ICS’s capital spend, and (b) the total value (£) of external vendor contracts commenced by East Suffolk and North East Essex ICS during the FY22/23 period, relevant the following areas:
(a)Cloud migration of patient data.
(b)The consolidation of patient information systems to support interoperability
(c)The development of performance analytics dashboards.
(d)AI tools within NHS services and clinician decision support
(e)The secure storage and transfer of NHS patient data.

FOI 4954 – 1. How many Community Diagnostic Centres do you have within your ICS or under ICB control ?
2. Please list your Community Diagnostic Centres
3. Do your Community Diagnostic Centres take blood tests?
4. How many patients have blood taken by the Community Diagnostic Centres take every week?
5. Do the Community Diagnostic Centres need paper blood forms to do blood tests?
a. From GP requests
b. From Hospital blood test requests

FOI 4955 – Does ICB have an in-house legal team that supports your continuing health care, s117 aftercare, responsible commissioner and transforming care teams? If yes how long has this been in place? If yes do you still use external legal support and if so how often?

FOI 4956 – 1. The ICB’s arrangements to enable providers to express an interest in providing services subject to Patient Choice and PSR Direct Award Process B
2. The ICB’s accreditation process for providers of services subject to Patient Choice and PSR Direct Award Process B
3. The name of the person responsible for Patient Choice at the ICB.

FOI 4957 – What is the distribution of different primary care EHR providers.

FOI 4958 – List of all PCNs for NHS Suffolk and North East Essex Integrated Care Board including the PCN manager for each, the Clinical Director and the Digital Transformation Lead.

FOI 4959 – Does the ICB commission Community Dermatology Services.

FOI 4960 – Please provide a list of all providers the ICB holds contracts with for Children and Young Peoples (CYP) Autism Spectrum Disorder Service.

FOI 4961 – Where does Palliative, End of Life Care and / or ‘Dying Well’ specifically feature in your overall planning documents?

FOI 4962 – Neurology & Dementia Service – Please provide a list of all providers the ICB holds contracts with for this service with service specification and service discription.

FOI 4963 – What is the total cost for all translation and interpretation activities for each of the financial years 21/22 and 22/23. I would like a separate total for each financial year.

FOI 4964 – Amount of money that is being spent on paying for beds in private mental health hospitals in an ad-hoc fashion due to NHS bed pressures.

FOI 4965 – Capital deployment to system partners for elective recovery and details of the ICB Senior Responsible Officer (SRO) for Elective Recovery and Planned Care.

FOI 4966 – NHS continuing healthcare applications made to the Suffolk and North East Essex Integrated Care Board (ICB) for the 2022/23 financial year.

FOI 4967 – Please confirm the ICB holds the following data, and where it is held please provide the data as requested.
Pain Management Services
1.Please provide a list of all providers the ICB holds contracts with for pain services, which could variously (but not exclusively) be described as:
a.Pain Clinic
b.Chronic Pain Service
c.Pain Medicine
d.Community Chronic Pain
2.For each contracted provider, please provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification).

FOI 4968 -What is the Suffolk and NE Essex blood glucose guidance.

FOI 4969 – Please provide a list of all providers the ICB holds contracts with for:

Paediatric allergy services:
Are they community or acute services
For each contracted provider, please provide the Service Specification that describes the service (whether
standalone or integrated in a broader Service Specification)

Cow’s Milk Allergy Services:
Please provide a list of all providers the ICB holds contracts with for Cow’s Milk Allergy services,
which are a subspecialty of paediatric allergy services. For each contracted provider, please provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification).

FOI 4970 – List of providers contracted to deliver ophthalmology services and the service specification from their contract.

FOI 4971 – How many GP practices in your ICB area are licensed visa sponsors currently?
How many GP practices in your ICB area were registered visa sponsors 12 months ago?
Is your ICB actively seeking to increase the number of GP practices in the area that are visa sponsors? If so, how.

FOI 4972 – What was your full-year budget for prescribing costs at the start of 23/24? Please also say what your planned prescribing spend was YTD at month 10*
Then forecast full-year spend on prescribing at year-end 23/24. Also actual prescribing spend YTD at month 10**
What was the assumed rate of growth in prescribing costs in your financial plan for 23/24, compared to 22/23
What is the most recent assessment of the actual rate of growth, compared to 22/23
For 22/23 and in the YTD at month 10**, please provide how much was spent on each group of drugs e.g. respiratory, CVD, mental health (i.e. categorised by BNF categories or similar).

FOI 4973 – Names of any independent sector providers (such as but not limited to ACES, CHEC, Newmedica, Optegra, Optimax and Spamedica) that provided cataract and/or YAG capsulotomy procedures for the ICB for the period 1st April 2022 to 31st March 2023.

FOI 4974 – What is the distribution of different electronic patient records (EPR) providers.

FOI 4975 – What is the number of serious incidents or never events that have been recorded by ophthalmology departments in relation to missed follow up appointments for wet AMD or glaucoma monitoring. By Missed it is meant delayed or remaining unbooked for hospital reasons such as lack of capacity rather than patient cancellations.

FOI 4976 – Number of doctors currently registered/approved to receive payment for undertaking MHA assessments.

FOI 4977 – Questions regarding Indwelling Catheters.

FOI 4978 – Information in relation to the purchasing of the following eyecare procedure with the following HRG code: BZ34A Phacoemulsification Cataract Extraction and Lens Implant, with CC Score 4+

FOI 4979 – From July 2022 to the end of January 2024, how many people receiving fast-track NHS continuing healthcare had their funding reviewed through an assessment.

FOI 4980 –

1. How many babies were born in your ICS from 1 April 2021 to 1 April 2023?
2. How many babies do you estimate there are aged 0-2 living in your Integrated Care System currently?
3. What proportion of them accessed Start for Life services during the period 1 April 2022 to 1 April 2023?
4. What percentage of babies aged 0-2 in your ICS are you commissioning specialised parent-infant relationship services for? i.e. a clinical psychologist or child psychotherapist led service.

FOI 4981 –

1. The number of Domiciliary Dental Contracts the Suffolk and North East Essex ICB commission
2. The specific termination/renewal date for each specific PDS Domiciliary Contract
3. The name of the current provider for each contract
4. The name and contact details for the lead commissioner

FOI 4982 – Organisation’s contract relating to energy management system.

FOI 4983 – Diagnostic testing in the ICB area.

FOI 4984 –

1. Please can you confirm which agencies have supplied healthcare workers to support complex care packages between 1st January 2023 and 31st December 2023.
2. Please can you confirm the associated spend per supplier of these workers, broken down by month for the same time period as specified in Q1.

FOI 4985 – Total spend on communications and public relations for the last three financial year’s (20/21,21/22,22/23).

FOI 4986 – Povide information about online sexual health testing services:
1.Does the authority commission or procure these services
2.In each of the financial periods 2021-22, 2022-23, April to December 2024
a.How much did the authority spend on these services
b.How many citizens were tested using online services
3.How much was spent (by the authority or predecessor organisations) in each period with each of the following providers for online sexual health services
a.Preventx
b.SH 24
c.TDL or their NHS joint venture, Health Service Laboratories
d.Viapath
e.Synlab or their joint venture, Synnovis
f.Lloyd’s pharmacy
g.NHS Trusts/ their laboratory services
h.Other. Please name any provider where the spend in any year exceeded £100,000
4.When did the authority last issue a tender for these services
5.When does the current contract expire.

FOI 4987 –  Full and entirety of the organisation’s contract register or database. The register should include the following columns/headings or something similar:
• Contract Reference -Unique reference number associated with the contract.
• Contract Title
• Procurement Category
• Supplier Name
• Spend (Total, Annual or contract value)
• Contract Duration
• Contract Extensions
• Contract Start Date
• Contract Expiry Date
• Contract Description [Please provide me with as much detail as possible.
• Contact Owner (Person that manages the contract register)
• Contact details of section 151 officer
• CPV codes/Pro-Class

FOI 4988 – Organisation’s gas and electricity contracts.

FOI 4989 – Who within the ICB, has the commissioning responsibility for supporting young adults and adults with learning disabilities, austism to come out of hospital settings back into the community? Please could you provide their:
a. Name
b. Job title
c. Telephone number
d. Email address

FOI 4990 – Please provide a list of all providers the ICB holds contracts with for the clinical specialty Endocrinology & Diabetes, Adults Gonadal Clinic Service, Adults Thyroid Clinic Service.
For each contracted provider provide the Service Specification that describes the service (whether standalone or integrated in a broader Service Specification).

FOI 4991 – Confirm the ICB holds the following data, and where it is held please provide the data as requested.

1.Bulimia Nervosa services
2.Binge Eating Disorder services
3.Post Traumatic Stress Disorder and/or Traumatic Stress services
4.Body Dysmorphic Disorder services
5.Obsessive Compulsive Disorder services

FOI 4992 – Does the ICB hold the data for Late Effects of Cancer Services, and where it is held, details are:

Late Effects/LE Service, Radiotherapy Late Effects Service
Pelvic, Pelvic Radiotherapy, Pelvic Radiation Disease/PRD Late Effects Service
Gastrointestinal & Urological, Gastrointestinal Late Effects Services
Gastrointestinal Consequences of Cancer service
Urological Late Effects Service
Radiation Cystitis clinic
Complex Cancer Late Effects Rehabilitation

FOI 4993 – Does NHS Suffolk and North East Essex ICB have any local treatment guidelines, pathways or protocols for treatment of Hidradenitis Suppurativa (Acne inversa)?

FOI 4994 – Senior Responsible Officers for:
Virtual Wards Elective Care (Outpatients)
Financial Management
Estates
Workforce
Continuing Health Care

FOI 4995 – Telephone details for the following people:

1. Continuing Healthcare
2. Learning Disability / Autism Lead
3. Mental Health Lead Berkshire West
4. Transforming Care Lead

FOI 4996 – Support service provision for multiple myeloma patients.

FOI 4997 – How much did your Trust spend in total on education and training in the following financial years?
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Please advise how much of this total spend was with external providers?
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Please can you break down the overall spend into the following categories?
Apprenticeship training
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Mandatory, statutory and compliance training
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Management and Leadership training
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Healthcare support worker training
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Nursing
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
Allied Healthcare Professionals
April to March 2021-2022 (overall spend)
April to March 2022- 2023 (overall spend)
What are the top five categories that you procure externally?

FOI 4998 – Current waiting times for young people being assessed for attention deficit hyperactivity disorder within your local area, e.g. when a young person is referred and how long it will take for them to be seen for an assessment/treatment.

FOI 4999 – 1.From the total winter resilience payments from NHS England to your ICB in the financial year 2023/24, what spend was committed to primary medical services (PCNs and/or GP surgeries)?
2.From within the ICB’s total budget in financial year 2023/24, what is the total committed spend on primary medical services (PCNs and/or GP surgeries) which is not delegated and wholly discretionary?

FOI 5000 – Which Helpdesk tool does the IT department use for managing tickets? When was the tool purchased? When is the existing contract due to end? When does the trust intend to review the solution with a view to potential replacement? Who is responsible for this solution.

FOI 5001  – Purchase of bed capacity in the private mental health sector.

FOI 5002 – List of NHS eye care services commissioned in primary and community settings and who are the contracted provider(s) of those services.
Confirmation of when any of these services are contracted until.
What are the commissioners’ intentions to improve primary and community eye care service provision?

FOI 5003 – Questions regardig NICE Quality Standard 204 on Fetal Alcohol Spectrum Disorder.

FOI 5004 – How many tier 4 referrals did Colchester set camhs make within the last 12 months?

FOI 4932 –  A request for latest organogram for the ICB/ICS which covers CHC (continuing healthcare) and gives the overview of the structure, manager/names and the locality leaders.

FOI 4933 – Number of IFRs (Individual Funding Request) the ICB has received for PANS (Paediatric Acute-onset Neuropsychiatric Syndrome)/PANDAS (Paediatric Autoimmune Disorders Associated with Streptococcal Infections) / Immune mediated component to behaviour.  How many of these have been accepted for an IFR.

FOI 4934 – 1.Do you have a specialist service for long Covid patients? Please name the clinic/service
2.How many patients in your local NHS area have been referred to the clinic/service to date?
3.How many staff do you have working in the service FTE (full time equivalent) broken down by job title of:
a) doctor
b) nurse
c) physiotherapist
d) occupational therapist
e) clinical psychologist/psychiatrist/ CBT practitioner
f) other, please specify
4.For any doctors employed, please specify their specialism e.g. GP, cardiologist, neurologist
5.Does the service have the ability in-house to prescribe medications to long Covid patients?
6.If so, please list the 3 most common drugs prescribed for long Covid patients by the clinic
7.Does the service have the ability to order tests and scans?
8.If so please list the 3 most commonly ordered tests/scans/diagnostic questionnaires for long Covid patients by the clinic
9.Please provide figures for how many patients referred to the clinic/service received the following type of treatment:
a) A wellbeing programme
b) physical rehabilitation
c) psychological support
d) A brain retraining or Neuro Linguistic Programming-based course such as the Lightning Process, Gupta Programme or Nuffield programme (please specify which)
d) drug treatment
e) other, please specify
10.If not provided in-house, which of the following types of services does the clinic/service refer patients on to or recommend?
a) A wellbeing programme
b) physical rehabilitation
c) psychological support
d) A brain retraining or Neuro Linguistic Programming-based course such as the Lightning Process, Gupta Programme or Nuffield programme (please specify which)
d) drug treatment
e) other, please specify
11.Is the clinic expected to continue running after 2025?
12.Which NHS trust is responsible for the care of patients referred to a long Covid clinic in your area?

FOI 4935 –

1. Who within the ICB, has the commissioning responsibility for care home placements for older people (aged 65+) under a Continuing Healthcare package (CHC)? Please provide their:
a.Name
b.Job title
c.Telephone number
d.Email address
2. Please provide the gross total expenditure on older person’s (age 65+) services under a CHC package for financial year 2020/21, 2021/22, 2022/23 (actual) and financial year 2023/24 (projected):
For question 2a, please provide total spend on personal social services for people aged 65+. This will include spend on residential, nursing, and domiciliary care (2b, 2c, and 2d) as well as other social care for older people such as day services, etc
a.Gross total expenditure on older person’s (65+) services
b.Gross total expenditure on residential home placements (65+)
c.Gross total expenditure on nursing home placements (65+)
d.Gross total expenditure on domiciliary care/home care (65+)
3. Please provide figures for the total number of older people (age 65+) that the ICB has placed under a CHC package in the financial year 2021/22, 2022/23 and 2023/24 (projected) and funded in:
a.Residential care
b.Residential dementia care
c.Nursing care
d.Nursing dementia care
e.Domiciliary care/home care
4. Please provide the average (mean) weekly fees paid for care home placements for older people (aged 65+) under a CHC package in financial year 2022/23 and 2023/24:
a. Older person’s residential
b. Older person’s residential dementia
c. Older person’s nursing
d. Older person’s nursing dementia

FOI 4936 –

1.Do you have Teledermatology services in all your area (please list them)?
2.What is the percentage of patients on the 2 Week Wait (2WW) suspected skin cancer pathway are rejected and referred back to primary care with “advice and guidance”? (for each service) (for 2022-2023; or if not available, for 2021- 2022)
3.Who is currently delivering teledermatology (NHS providers – community, hospitals, GPs; or private providers, others)? (for each service)
4.Where are these delivered (primary care facilities, community hospitals, community diagnostic centres)? (for each service)
5.What type of dermoscopic equipment(s) are used to take high quality images? (for each service)
6.What teledermatology image sharing platform(s) are used? (for each service)
7.Are these services commissioned per patients or per lesion-mole or as contracted service?
8.What is the duration of these service contract(s) and when will they end?
9.Please provide any links for on-going teledermatology procurement exercises
10.Is the budget for teledermatology service(s) held by the ICB or devolved to the community (please specify)?

FOI 4937 – How many community diagnostic centres are open across the ICB, their postcode, and what date they were first operational. The number of appointments they have fulfilled per month since opening and the number of NHS staff working on site, and contracted staff working on site.

FOI 4938 –

1.Are you partnering with any other private or public sector organisations to deliver your Personal Health Budgets (PHBs)? If so, please provide the names of those organisations and a summary of the services they provide?
2.Who is responsible for the delivery of the PHB targets (e.g. PHB Lead) and what are their contact details (name, email and phone number)?
3.Who is responsible for the delivery of the Continuing Healthcare programme and what are their contact details (name, email and phone number)?
4.Who is the Personalised Care or Personalisation Lead/Personalised Care Operations Lead at the ICB and what are their contact details ((name, email and phone number)?
5.Who is the Integrated Care Lead at the ICB and what are their contact details (name, email and phone number)?
6.Who is responsible for improving faster hospital discharges at the ICB and what are their contact details (name, email and phone number)?
7.Who is the Urgent & Emergency Care Lead at the ICB and what are their contact details (name, email and phone number)?
8.Who is responsible for the digital transformation within the ICB and what are their contact details (name, email and phone number)?
9.Who is the current Director of Finance within the ICB and what are their contact details (name, email and phone number)?
10.How many people in your ICB have been awarded a Continuing Healthcare budget and how many of these have taken up a PHB?
11.Excluding wheelchair budgets, how many PHBs have been awarded in the last 12 months and what is the average PHB budget value?
12.What was total annual spend on PHBs for your ICB and how does that spend break down by Direct Payment, 3rd party managed and notional budgets?
13.What software, if any, is used to manage PHBs and direct payments in your ICB?
14.What is the total annual cost for this software and what licensing model is used, e.g., X% of budget/per user/fixed cost
15.When is the contract for the PHB software up for renewal?
16.If not in use already, are you considering digital automated services to assist with the delivery of services and budget management of your PHBs, personal budgets, direct payments and integrated personal budgets?
17.Do you use a Direct Payment Support Service (DPSS) to assist direct payment recipients and if so, please provide details of who this is?
18.Is the DPSS a contracted service and if so when does that contract expire?
19.What is the annual cost of the DPSS?

FOI 4939 – How many IPC (Intermittent Pneumatic Compression sleeves) does the Trust purchase each year covering 2022-2023? Which brand? Where from?

FOI 4940 – How many AES(Anti-Embolism Stockings) does the Trust purchase per year covering 2022-2023? Which brand? Where from?

FOI 4941 – What are the contractual performance KPI’s for key worker contracts which have been developed as a response to the NHS England & NHS Improvement Long Term Plan (LTP) commitment that by 2023/24, children and young people with a learning disability, autism or both, with the most complex needs will have a designated Keyworker.

FOI 4942 – Practice list closures (not accepting new patients).

FOI 4943 –  What Learning Disabilities support does ICS offer to adults aged 18-64.

FOI 4944 – Does your ICB commission Tier 3 weight management services.

FOI 4945 – Who are the ICB’s current contracted providers for tertiary level IVF/Fertility Specialist services?
Who are the ICB’s current contracted providers for secondary level reproductive medicine/sub fertility services?
Who have held the ICB/CCG’s contracted providers for tertiary level IVF/Fertility Specialist services and for what time period/dates since 2012
Who are the ICB’s/CCGs contracted providers for secondary level reproductive medicine/sub fertility services and for what time period/dates since 2012
When was the last procurement exercise undertaken for IVF/Fertility Specialist services?
When is it expected the next procurement exercise will be undertaken for IVF/Fertility Specialist services?
Is there a fixed tariff for IVF? If so what is this if not what is the tariff per current provider
What volume of activity did the ICB commission for IVF and ICSI services per year from 2012?
What volume of activity did the ICB commission for IUI services per year from 2012?
What volume of egg and or sperm donor services did the ICB commission per year from 2012?

FOI 4946 -Information for each of the previous 3 financial years, namely 2018/19 2019/20 2020/21.

• The total expenditure by the ICB on cataract surgery
• The total expenditure by the ICB on cataract surgery in the non-nhs independent sector
• The total expenditure by the ICB on cataract surgery in the NHS
• The total cataract surgery activity commissioned by the ICB in the non-nhs independent sector
• The total cataract surgery activity commissioned by the ICB in the NHS.

FOI 4947 – What is the number of UK nationals employed at your organisation in the 3 calendar years 2016, 2022, and 2023 & the number of non-UK nationals employed at your organisation for the same years.

FOI 4948 – How much has the ICB spent on inpatients with a learning disability and/or autism (who meet the NHS Digital Assuring Transformation criteria*) for the time period April 2022 – March 2023.

FOI 4949 – Please supply the average daily rate for a person with a learning disability and/or autistic person in an inpatient bed commissioned by the ICB in the financial year 22/23 where the patient was included in the Assuring Transformation criteria.

FOI 4950 – What is the allocation of funds attributed to the Better Care Fund (BCF).

FOI 4951 -How many people under the age of 18 were admitted by paramedics or police to a&e  due to mental health  between 01 December 2023 – 26 December 2023?

FOI 4952 – What is the the total expenditure made by your organisation, in every facet of its operations and purview, on translation, interpretation, and language services for years 2020-2023.

FOI 4953 – Between the 1st of September 2022 and the 31st of August 2023:
1. How many patients registered within your ICB footprint were readmitted as emergency admissions within 30 days of any discharge from secondary who were receiving any dose of Dalteparin at the time of readmission?
2. How many patients registered within your ICB footprint were readmitted as emergency admissions within 30 days of any discharge from secondary who were receiving any dose of Enoxaparin at the time of readmission?
3. How many patients registered within your ICB footprint were readmitted as emergency admissions within 30 days of any discharge from secondary who were receiving any dose of Tinzaparin at the time of readmission.

FOI 4882 – The total value the ICB has been invoiced by care homes between 1 July 2022 and 30 June 2023.

FOI 4883 – What ophthalmology services ICB commissions within NHS Trusts and private providers.

FOI 4884 – In relation to SNEE ICB, in March 2023 how many people had: Continuous health care (CHC) & Funded nursing care (FNC).

FOI 4885 – Has the ICB or any of its system partners mobilised surge wards during FY 2022/2023 or in FY 2023/2024 (to date).

FOI 4886 – Which wheelchair services does ICB oversee.

FOI 4887 – Names of all ‘place’ structures and forums within the ICS, ICB and ICP, including all place-based partnerships/place provider partnerships/collaboratives or lead provider arrangements; including place-based provider collaboratives.

FOI 4888 – Questions in relation to the role of CIO and professionalism.

FOI 4889 – Name the organisation(s) that deliver(s) ASD (autism spectrum disorder) and ADHD (attention deficit hyperactivity disorder) assessments / diagnoses in your ICB area for both adults and CYP (children and young people).

FOI 4890 – Does the ICB have a policy regarding abuse, violence or aggression towards primary care staff by patients.

FOI 4891 – Mental health patients in a rehab and recovery unit, patients occupying a bed for specialist neuropsychiatry disorders, and patients with an acquired brain injury occupying a level 3 neuro-rehab facility bed.

FOI 4892 – Which primary care rebate schemes is your ICB/ Health Board currently signed up to.

FOI 4893 -Does NHS Suffolk and North East Essex ICB and its local authorities that are part of NHS Suffolk and North East Essex ICS have an agreed Dementia Strategy (10-year plan) for its Mental Health commissioning priorities?

FOI 4894 – Are there AQP providers for audiology in the ICB area.

FOI 4895 – Has the ICB you run an incentive scheme (or similar) to effect change in prescribing with your GP practices since 2019.

FOI 4896 – Org design with the names and email addresses and contact numbers of all your central functions Directors.  Specifically, Directors of Finance, BI, Health and IT.

FOI 4897 – ARRS spend of PCNs for the 2023/24 Financial Year (April-November).

FOI 4898 – Total number of health services commissioned through the public contract regulations, by quarter, since 2019 to September 2023.

FOI 4899 – Postural Tachycardia Syndrome PoTS

FOI 4900 – Number of Caesarean Section births performed with forceps assisted delivery in the last 12 months at Ipswich Hospital.

FOI 4901 – Structure and staffing of the ICB services provided by SNEE ICB, including the Continuing Healthcare (CHC) team, Personal Health Budget (PHB) team, Individualized Funding Care staff, and Safeguarding team.

FOI 4902 – The number of out-of-area (OOA) placements as well as the number of people with a delayed transfer of care (DTOC) in an in-patient setting for the following conditions:
i.)Mental Health (MH) conditions – Patients in a rehab and recovery unit inpatient bed
ii.)Neuropsychiatry (NP) disorders – Patients in a specialist neuropsychiatry inpatient bed.
iii.)Acquired Brain Injuries (ABI) condition – Patients in a level-3 neuro-rehab facility in-patient bed.

FOI 4903 – Which Trust(s)/Organisation(s) your ICB commissions to undertake Adult Autism Assessments and Diagnosis.

FOI 4904 – Periocular and facial surgical funding policies for patients with thyroid eye disease (TED) or facial nerve palsies (FNP) within ICB.

FOI 4905 – Does the ICB fund the enteral feeding of children and young people in education settings (eg early year settings, mainstream schools and specialist provision).

FOI 4906 – What is ICB’s estimated YTD deficit, and how much of this has been caused by industrial action.

FOI 4907 – What is ICB’s budget for dentistry this financial year.

FOI 4908 – What is the new financial plan that has been reportedly requested from NHS England, and will ICB publish it.

FOI 4909 – Do you have a dedicated service for lower limb wounds in your ICB.

FOI 4910 – Which of the following high impact intervention areas have been chosen as an priority this winter: Please see highlighted areas:
o Same day emergency care
o Frailty
o Inpatient flow and length of stay (Acute)
o Community bed productivity and flow
o Care transfer hubs
o Immediate care demand and capacity
o Virtual wards
o Urgent community response
o Single point of access
o Acute respiratory infection hubs.

FOI 4911 – How many Managers are currently employed in your Trust and

FOI 4912 – The amount your ICB has spent with the private provider Mountain Healthcare Ltd to deliver sexual assault referral centre services between Oct 2021 to Sept 2022.

FOI 4913 – Digital Strategy, Data strategy, Cyber security plan.

FOI 4914 – Please can you send me the names of the members of staff in the following positions:

• CFO
• Head Of Finance
• Head OF HR
• Head Of Procurement
• Head Of Estates
• Finance Manager
• HR Manager
• Estates Manager
• Procurements Manager

FOI 4915 – The director (or senior manager) of ICT services, their email and telephone number.

FOI 4916 – Medicine pill pouches.

FOI 4917 – For the last financial year, what was the total amount spent on translation costs.

FOI 4918 – Does your ICS manage any patient referrals centrally, or is this only done by a Trust.

FOI 4919 – How much money the ICB has spent In solicitors fees between Jan 2021 to present – not including employment claims.

FOI 4920 – How does ICB commission children’s palliative care for children and young people with life-limiting and life-threatening conditions.

FOI 4921 – Information regarding capital spending following central government funding offers.

1) What was the longest A&E wait across the ICB in:
a) 2023.
b) 2022.

2) How many new ambulances have you bought in across 2023, (if applicable) the number of ambulances due to be bought in by the end of FY23/24.

3) Total ambulance fleet at 1.1.2023 and on 1.12.2023.

4) The number of virtual beds on 1.1.2023, 1.3.2023 and on 1.12.2023.

FOI 4922 – List of GP Practices and their email addresses for all the GP Practices in the Suffolk and North East Essex area.

FOI 4923 – Please provide:

1. The name of the lead officer responsible for the Telecare analogue to digital switchover, their email address, and phone number
2. The number of Telecare recipients
3. An approximate percentage of completion to switching over from analogue to digital telecare boxes
4. The name of the supplier of the Telecare alarm receiving centre software that is utilised.

FOI 4924 – Discharge hub/ transfer of care hub in the ICB

FOI 4925 – Summary of the current/live community cardiology contracts (including Echocardiography and ECG) across the NHS Trusts within the Suffolk & N E Essex ICB footprint. Including:
-Contract start and end dates
-Contract value
-Current provider of the service(s)

FOI 4926 – Packages of care funded under NHS Continuing Healthcare that are provided in the service users own home. Mainly packages of care provided by home care agencies or domiciliary care provider.
a) How many packages involve the commissioning/funding of a nurse for 24 hours a day?
b) How many packages of care fall within the cost bracket of £10,000 to £11,000 a week?
c) How many packages of care fall within the cost bracket £11,000 to £12,000 a week?
d) How many packages of care fall within the cost bracket of £12,000 to £13,000 a week?
e) How many packages fall within the cost bracket of £13,000 to £14,000 a week?
f) What is the budget/cost of the most expensive package of care? This can be weekly or annual budget, rounded to the nearest £1000 to avoid identifying the package by giving exact budget.

FOI 4927 –

1.Since 1st January 2022 how many staff have been given permission to work remotely outside of the UK?
2.List unique approval detailing; country, job title of the individual concerned and length of time spent working outside of the UK.
3.Are there any additional associated costs created by staff working outside of the UK. Please provide a breakdown of these costs and the total spent since 1st January 2022.

FOI 4928 – Has the ICB set aside a budget this current year to address Health Inequalities, if so, please can you state the budget.

FOI 4929 – Which geographical area do you commission orthodontic services for? Suffolk & North East Essex (excluding any area which comes under Norfolk & Waveney).

FOI 4930 – List of practices which have not signed up to PCNs  or have they signed Data Sharing Agreements with the PCNs.

FOi 4931 – How many private v NHS-funded patients did your trust treat for IVF in the financial year 2012-2013 and in the same period for 2022-2023? Please can you break this down by year and state whether they were private patients or NHS patients.

FOI 4843 – Record of any complaints made against physician associates since 2020.

FOI 4844 – Referral pathways for Gastroenterology and Direct Access Endoscopy.

FOI 4845 – Names of supplier(s) contracted for flexible pool solutions by the ICB.

FOI 4846 – How many assessments led to a recommendation of eligibility and how many did not.

FOI 4847 – NHS agency/locum spending cap/ceiling.

FOI 4848 – In your Integrated Care System area, how many patients have you seen with insomnia over the last 12 months.

FOI 4849 – Locked rehabilitation placements for adults with all mental health diagnosis.

FOI 4850 – Total sum of items provided to community users by ICB’s Community Equipment Store.

FOI 4851 – SNEE ICB’s local treatment guidelines, pathways or protocols for the use of human growth hormone.

FOI 4852 – Budget and spend by the ICS to maternity and neonatal services in 2021/22, 2022/23 and 2023/24.

FOI 4853 – Providers of pain clinics in the ICB over the past two NHS financial years.

FOI 4854 – ICB’s digital strategy & regional shared care record.

FOI 4855 – SNEE ICB’s contact information for the Provider or Trust responsible for decision-making and the purchasing of services.

FOI 4856 –  Clinical ICT Strategy

FOI 4857 – The total number of expectant mothers in your area.

FOI 4858 – Management of regional patient flow.

FOI 4859 – Expiry date of your Minor and Urgent Eyecare community service.

FOI 4860 – Spending on private provision/ out of area placements.

FOI 4861 – Guidelines for the treatment of insomnia in adult patients.

FOI 4862 – SNEE ICB’s number of permanently employed staff split by band, gender and ethnicity.

FOI 4863 – Amount or percentage of funding allocated to virtual ward development/implementation or support.

FOI 4864 – ICS’s contracts with private hospitals to provide surgeries and tests to NHS patients.

FOI 4865 – ICB’s Chief Pharmacist.

FOI 4866 – Referral management centre protocol for patient’s of 5 providers for consultant led, elective care for Ophthalmology.

FOI 4867 – Last networking (LAN, Core & Edge refresh) and when is the next refresh planned.

FOI 4868 – Collaborative lipids fund (CLF).

FOI 4869 – Confirmation of ICB operating on a CHC framework with a single, or range of rates.

FOI 4870 – What are the contractual performance KPIs for the service of Musculoskeletal/Physiotherapy.

FOI 4871 – What proportion of GP practices are doing spirometry themselves.

FOI 4872 – Senior leadership team.

FOI 4873 – Is there a TLHC programme running in your system.

FOI 4874 – ICB founded continence pads & containment product for disabled children and young people living in ICB’s area.

FOI 4875 – How many Adults are receiving CHC funded care in their own homes under certain categories.

FOI 4876 – How does the NHS pay for prescriptions filled by pharmacies.

FOI 4877 – Details of NHS staffing expenditure in the ICB/ICS area in Occupational Health and Occupational Health and Wellbeing for 2020, 2021 and 2022.

FOI 4878 – Social media management platform.

FOI 4879 – Eligibility decisions for NHS Continuing Healthcare.

FOI 4880 – Medium-term financial plan for the ICS.

FOI 4881 – How many applications for support under the HTCS were made to the ICB.